Clinical Trials - TAK

NCT IDTitleStatusPhasesStart DateCompletion DatePrimary Completion Date
NCT06579755A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years)NOT_YET_RECRUITINGPHASE32026-04-012027-04-142027-04-14
NCT07205718A Study of TAK-188 in Adults With Advanced or Spreading Solid TumorsNOT_YET_RECRUITINGPHASE1, PHASE22025-11-182029-12-212028-12-26
NCT07047521A Study on a New Tetravalent Dengue Vaccine (TDV) Formulation in Healthy AdultsNOT_YET_RECRUITINGPHASE32025-11-172027-07-302026-08-30
NCT07108283A Study of Zasocitinib in Adults With Nonsegmental VitiligoNOT_YET_RECRUITINGPHASE22025-11-142027-11-092027-10-12
NCT06405087A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)NOT_YET_RECRUITINGPHASE32025-10-222032-01-262032-01-26
NCT07129343A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)NOT_YET_RECRUITINGPHASE32025-10-122027-11-252027-11-25
NCT07204314A Study of Vortioxetine in Japanese Pediatric Patients With Major Depressive DisorderNOT_YET_RECRUITINGPHASE32025-10-012029-09-302029-09-30
NCT06980480A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple MyelomaNOT_YET_RECRUITINGPHASE32025-09-082028-09-112028-09-11
NCT06948318A Continuation Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRECRUITINGPHASE32025-08-142029-07-292029-07-29
NCT06963827A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney ConditionRECRUITINGPHASE32025-07-152030-01-142028-09-07
NCT06973291A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque PsoriasisRECRUITINGPHASE32025-07-092026-07-032026-06-05
NCT06973304A Study of Teduglutide in Chinese Adults With Short Bowel SyndromeRECRUITINGPHASE32025-06-262027-07-282027-02-10
NCT06665035A Study of 2 Doses of Tetravalent Dengue Vaccine (TDV) in Infants and ToddlersRECRUITINGPHASE32025-06-162030-03-032030-03-03
NCT02442752Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 MonthsWITHDRAWNPHASE12025-06-152025-12-232025-12-23
NCT06377228A Study of TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc)WITHDRAWNPHASE12025-06-132030-09-022030-09-02
NCT06764615A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)RECRUITINGPHASE22025-05-282029-12-302029-12-30
NCT06798012A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)RECRUITINGPHASE22025-05-142028-06-082027-12-02
NCT06747351A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)RECRUITINGPHASE32025-05-062028-06-252028-06-25
NCT06499285The Efficacy and Safety of Elritercept in Adult Participants With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) With Anemia (RENEW)RECRUITINGPHASE32025-05-062032-052028-05
NCT06952699A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)RECRUITINGPHASE22025-05-062026-04-232026-03-23
NCT06935266A Study of TAK-881 With and Without Ramp-Up Dosing in Healthy AdultsRECRUITINGPHASE12025-04-222025-10-212025-10-21
NCT06581328A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in the Community SettingRECRUITINGPHASE42025-03-272028-06-012027-10-01
NCT06895967A Study of TAK-881 and HyQvia in Healthy AdultsCOMPLETEDPHASE12025-03-242025-07-242025-07-24
NCT06671496A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic MedicinesRECRUITINGPHASE32025-03-102028-01-262027-05-18
NCT06671483A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesRECRUITINGPHASE32025-03-032028-01-282027-05-18
NCT06722235A Study of Mezagitamab in Adults With Chronic Primary Immune ThrombocytopeniaRECRUITINGPHASE32025-02-272027-12-282027-12-28
NCT06812078A Study of TAK-360 in Adults With Idiopathic HypersomniaRECRUITINGPHASE22025-02-072026-02-192026-02-19
NCT06741683A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in JapanACTIVE_NOT_RECRUITINGPHASE2, PHASE32025-01-312025-12-312025-07-09
NCT06793943A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy AdultsCOMPLETEDPHASE12025-01-232025-03-302025-03-11
NCT06100289A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's DiseaseRECRUITINGPHASE32025-01-222027-06-302027-06-30
NCT06562543A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal CancerRECRUITINGPHASE42025-01-142027-10-042027-10-04
NCT06227910A Study of Vedolizumab With and Without Upadacitinib in Adults With Crohn's DiseaseRECRUITINGPHASE32025-01-022028-08-012027-06-08
NCT06439342A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) InfectionsRECRUITINGPHASE32024-12-162026-12-312026-12-31
NCT06443502A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic PouchitisRECRUITINGPHASE32024-11-192029-12-312029-12-31
NCT05582993A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)RECRUITINGPHASE32024-11-062030-04-112030-04-11
NCT06076642A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency DiseasesRECRUITINGPHASE32024-11-042029-01-152029-01-15
NCT06236009A First-In-Human Study of TAK-004 in Healthy AdultsCOMPLETEDPHASE12024-11-012025-10-062025-10-06
NCT06505031A Study of TAK-861 in People With Narcolepsy Type 1COMPLETEDPHASE32024-10-082025-06-042025-06-04
NCT06550076A Study of TAK-279 in Participants With Moderate-to-Severe Plaque PsoriasisRECRUITINGPHASE32024-09-042026-05-072026-05-07
NCT06831370A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in IndiaRECRUITINGPHASE42024-08-282026-03-312026-03-31
NCT06470828A Study of TAK-861 for the Treatment of Narcolepsy Type 1COMPLETEDPHASE32024-07-022025-06-032025-06-03
NCT06111547A Study of TAK-279 in Healthy Chinese AdultsCOMPLETEDPHASE12024-06-242024-08-042024-07-23
NCT06095128A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)RECRUITINGPHASE42024-06-122027-07-092027-07-09
NCT06390995A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid TumorsACTIVE_NOT_RECRUITINGPHASE1, PHASE22024-05-202027-03-192025-04-16
NCT06258265A Study of TAK-279 in Healthy Adults on the Effect on ECG MeasurementsCOMPLETEDPHASE12024-04-292024-07-092024-06-25
NCT06422377A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to FenfluramineTERMINATEDPHASE32024-04-252024-08-142024-08-14
NCT06045754A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's DiseaseRECRUITINGPHASE42024-04-182027-06-282027-06-28
NCT06254950A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative ColitisRECRUITINGPHASE22024-03-292027-08-042026-09-30
NCT06060067A Study of Dengue Vaccine in Healthy Children, Teenagers and Adults in IndiaCOMPLETEDPHASE32024-03-292025-05-052025-05-05
NCT06290050A Study of the Interaction of Other Drugs With TAK-279 in Healthy AdultsCOMPLETEDPHASE12024-03-292024-05-162024-05-03
NCT06323356A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic PsoriasisACTIVE_NOT_RECRUITINGPHASE32024-03-192026-07-222025-10-15
NCT06233461A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's DiseaseRECRUITINGPHASE22024-03-052027-07-232026-09-18
NCT06031259Extension Study of Idursulfase-IT Along With Elaprase in Children and Adults With Hunter Syndrome and Cognitive ImpairmentACTIVE_NOT_RECRUITINGPHASE2, PHASE32024-03-052029-01-012029-01-01
NCT06165341Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)RECRUITINGPHASE32024-03-012028-08-262028-08-26
NCT05469802A Study of Purified Inactivated Zika Virus Vaccine (PIZV) in Healthy AdultsWITHDRAWNPHASE22024-01-022024-07-052024-07-05
NCT05466747A Study of RYMPHYSIA for Alpha1-Proteinase Inhibitor (A1PI) Therapy in Adults With A1PI Deficiency and Chronic Obstructive Pulmonary Disease (COPD)-EmphysemaWITHDRAWNPHASE42024-01-012029-05-072027-04-26
NCT06132867A Study to Compare the Relative Bioavailability of Brigatinib When Swallowed as a Solution Versus When Swallowed as a Tablet in Healthy AdultsCOMPLETEDPHASE12023-12-202024-02-172024-02-17
NCT05976334An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid TumorsTERMINATEDPHASE12023-11-142024-07-162024-06-21
NCT05319353A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)RECRUITINGPHASE32023-11-132027-01-182027-01-18
NCT06088043A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of TreatmentACTIVE_NOT_RECRUITINGPHASE32023-11-062025-11-042025-01-22
NCT06108544A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment PeriodACTIVE_NOT_RECRUITINGPHASE32023-11-062025-11-072024-12-06
NCT05755035A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency DiseasesACTIVE_NOT_RECRUITINGPHASE2, PHASE32023-10-242026-09-302026-02-10
NCT05891158A Study About Fazirsiran in People With and Without Liver ProblemsCOMPLETEDPHASE12023-10-052025-09-032025-09-03
NCT05992155A Study of TAK-279 in Adults With or Without Kidney ProblemsCOMPLETEDPHASE12023-09-272024-05-282024-05-22
NCT05976321A Study of TAK-279 in Adults With or Without Liver DamageCOMPLETEDPHASE12023-09-222024-04-152024-04-15
NCT05995249A Study of the Interaction of TAK-279 With Substances That Have an Impact on Metabolism in Healthy AdultsCOMPLETEDPHASE12023-08-112023-12-312023-12-18
NCT05899673An Extension Study to Learn About the Long-Term Safety of Fazirsiran and if Fazirsiran Can Help People With Alpha-1 Antitrypsin Liver DiseaseACTIVE_NOT_RECRUITINGPHASE32023-08-082033-05-022033-05-02
NCT05918822A Study of Maribavir Pediatric Formulation in Healthy Adult ParticipantsCOMPLETEDPHASE12023-07-252023-09-012023-08-25
NCT05886491A Study of GDX012 in Adults With Relapsed or Refractory Acute Myeloid LeukemiaACTIVE_NOT_RECRUITINGPHASE1, PHASE22023-07-112026-05-122025-08-19
NCT05437211A Proof-of-concept Study to Reduce Treatment Burden in Haemophilia Participants Receiving Factor VIII and Factor IX InfusionsCOMPLETEDNA2023-06-232024-02-212024-02-21
NCT05837897A Study of Vedolizumab in Adult Participants With Moderate to Severe Crohn's DiseaseRECRUITINGPHASE32023-06-162031-05-302030-03-08
NCT05818956A Study of TAK-227 in Healthy AdultsCOMPLETEDPHASE12023-05-252023-06-262023-06-19
NCT02615184A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years OldRECRUITINGPHASE22023-05-232027-10-312027-10-31
NCT05442567A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)RECRUITINGPHASE32023-05-162031-08-152031-08-15
NCT05814016A Study of Danavorexton in People With Obstructive Sleep Apnea After General Anesthesia for Abdominal SurgeryTERMINATEDPHASE22023-05-112024-09-252024-09-25
NCT05816382A Study of TAK-861 for the Treatment of Selected Central Hypersomnia ConditionsRECRUITINGPHASE2, PHASE32023-04-052028-02-282028-02-28
NCT05707351A Study of Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia ACOMPLETEDPHASE32023-03-272024-09-052024-09-05
NCT05714969A Study of TAK-755 (rADAMTS13) With Little to No Plasma Exchange (PEX) Treatment in Adults With Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)RECRUITINGPHASE22023-03-212026-06-112026-06-11
NCT05341115A Study of Leuprolide Acetate Depot in Children With Central Precocious PubertyCOMPLETEDPHASE42023-03-142025-03-102024-12-19
NCT05677971Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin ProteinRECRUITINGPHASE32023-03-062030-08-142028-02-17
NCT05494593A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)RECRUITINGPHASE42023-02-282028-07-172028-07-17
NCT02616302A Study to Check the Safety of Dexlansoprazole and Learn if it Can Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Children 2 to 11 Years OldRECRUITINGPHASE22023-02-202027-10-312027-10-31
NCT05673785A Study of Brentuximab Vedotin in Combination With Cyclophosphamide, Doxorubicin (Hydroxydaunorubicin), Prednisone (CHP) in Chinese Participants With CD30-Positive (CD30+) Peripheral T-Cell Lymphomas (PTCL)ACTIVE_NOT_RECRUITINGPHASE22023-02-102027-12-312025-04-27
NCT06268301A Study to Determine the Effect Food Has on TAK-721 (Budesonide Oral Suspension) in the Body of Healthy AdultsCOMPLETEDPHASE12023-02-062023-02-202023-02-17
NCT05590377A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple MyelomaTERMINATEDPHASE1, PHASE22023-01-232024-05-222024-05-22
NCT07052682A Study to Evaluate How Ontamalimab Works and Assess Its Safety and Tolerability in People With Nonalcoholic Steatohepatitis With Fibrosis Stages 1 to 4TERMINATEDPHASE12023-01-182024-12-302024-12-30
NCT05543174A Study of TAK-625 for the Treatment of Alagille Syndrome (ALGS)COMPLETEDPHASE32023-01-162025-07-252023-10-25
NCT05556616A Study of Modakafusp Alfa in Adult Participants With Multiple MyelomaTERMINATEDPHASE12023-01-122024-06-042024-06-04
NCT05543187A Study of TAK-625 for the Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC)COMPLETEDPHASE32023-01-102025-07-222023-09-04
NCT05687903A Study of TAK-861 in Participants With Narcolepsy Type 1COMPLETEDPHASE22023-01-092023-12-142023-12-14
NCT05687916A Study of TAK-861 in Participants With Narcolepsy Type 2COMPLETEDPHASE22023-01-092023-12-252023-12-13
NCT05529992A Study of Velaglucerase Alfa (VPRIV) in Chinese Children, Teenagers, and Adults With Type 1 Gaucher DiseaseCOMPLETEDPHASE32023-01-032024-08-052024-08-05
NCT05442554A Study of Brentuximab Vedotin Treatment in Chinese Adults With CD30-Positive Cutaneous T-Cell LymphomaCOMPLETEDPHASE42022-11-282024-08-092024-08-09
NCT05602818A Study of Soticlestat in Healthy Adult Nondependent Recreational Drug Users With Central Nervous System (CNS) Depressant ExperienceCOMPLETEDPHASE12022-11-152023-07-072023-06-29
NCT05526391A Study of TAK-341 in Treatment of Multiple System AtrophyCOMPLETEDPHASE22022-11-092025-07-282025-07-28
NCT05174221A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background TherapyACTIVE_NOT_RECRUITINGPHASE12022-11-092026-03-232026-03-23
NCT05067868A Study of Replagal in Children and Adults With Fabry Disease in IndiaRECRUITINGPHASE42022-11-012026-11-302026-10-31
NCT05309902A Study of Soticlestat in Healthy Adults To Evaluate the Effect on QTc IntervalWITHDRAWNPHASE12022-10-112022-12-062022-12-06
NCT05513586A Study to Evaluate the Long-term Safety of TAK-771 in Japanese Primary Immunodeficiency Disease (PID) ParticipantsACTIVE_NOT_RECRUITINGPHASE32022-09-132025-10-312025-10-31
NCT03878953A Clinical Study of rhPTH(1-84) Treatment in Japanese Participants With Chronic HypoparathyroidismWITHDRAWNPHASE32022-08-312023-05-312023-05-31
NCT05156983A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent SurgeryRECRUITINGPHASE32022-08-242028-04-122028-04-12
NCT05353985A Study of TAK-062 in Treatment of Active Celiac Disease in Participants Attempting a Gluten-Free DietCOMPLETEDPHASE22022-06-302024-11-062024-11-06
NCT05183139A Multicenter In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple MyelomaWITHDRAWNPHASE42022-06-302026-12-312026-12-31
NCT04530123Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free DietACTIVE_NOT_RECRUITINGPHASE22022-06-232026-01-192026-01-19
NCT05460325A Study of Lanadelumab (SHP643) in Chinese Participants With Hereditary Angioedema (HAE)COMPLETEDPHASE32022-06-222023-11-282023-11-28
NCT05382104Maribavir Food-Effect Study in Healthy Adults ParticipantsCOMPLETEDPHASE12022-05-252022-07-022022-07-02
NCT04974749A Study of REPLAGAL® in Treatment-naive Chinese Participants With Fabry DiseaseCOMPLETEDPHASE32022-05-012024-01-032024-01-03
NCT04779320A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)RECRUITINGPHASE32022-04-302026-05-222026-05-22
NCT05220098First-in-Human Study of TAK-280 in Participants With Solid TumorsTERMINATEDPHASE1, PHASE22022-04-222025-07-282025-07-28
NCT05058391A Study of Elaprase in Children and Adults With Hunter Syndrome (Mucopolysaccharidosis II) in IndiaCOMPLETEDPHASE42022-04-212024-04-182024-04-06
NCT05299359A Single Heterologous Booster Vaccination Study of TAK-019 in Healthy Japanese Adults (COVID-19)COMPLETEDPHASE32022-04-152023-10-182022-06-11
NCT05070247A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid TumorsTERMINATEDPHASE1, PHASE22022-04-142025-01-062025-01-06
NCT05284760A Study of Soticlestat Tablets in Healthy AdultsCOMPLETEDPHASE12022-03-112022-06-022022-05-22
NCT05180890A Study of Danavorexton (TAK-925) in Adults With Obstructive Sleep ApneaCOMPLETEDPHASE12022-03-102022-11-232022-11-23
NCT05163314A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut SyndromeTERMINATEDPHASE32022-03-042025-09-242025-09-24
NCT06768658A Study of TAK-951 in Participants With Cyclic Vomiting Syndrome (CVS)TERMINATEDPHASE12022-03-022023-01-092023-01-09
NCT05150340A Study of TAK-771 in Japanese People With Primary Immunodeficiency Diseases (PID)COMPLETEDPHASE32022-01-242023-08-282023-08-28
NCT05084053A Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN)ACTIVE_NOT_RECRUITINGPHASE32022-01-192025-10-312024-03-05
NCT05137717A Study of Maribavir in Japanese People With Cytomegalovirus (CMV) InfectionCOMPLETEDPHASE32022-01-182023-06-272023-06-27
NCT04985682A Study of ADVATE in People With Hemophilia A in IndiaCOMPLETEDPHASE42022-01-142023-02-102023-02-10
NCT06610279A Study of TAK-951 in Healthy AdultsTERMINATEDPHASE12022-01-072023-09-212023-09-21
NCT05153148A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic ArthritisCOMPLETEDPHASE22022-01-062023-06-022023-05-04
NCT05164666A Study of TAK-103 in Adult With Solid TumorsTERMINATEDPHASE12022-01-052025-02-222025-02-22
NCT05027308A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or OlderCOMPLETEDPHASE32022-01-042023-09-272023-09-27
NCT04840667A Study of Replagal in Treatment-naïve Adults With Fabry DiseaseTERMINATEDPHASE32021-12-282022-12-162022-12-16
NCT05037760Study to Evaluate KER-050 as a Monotherapy or in Combination With Ruxolitinib in MyelofibrosisRECRUITINGPHASE22021-12-162029-012026-12
NCT04804540A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's DiseaseCOMPLETEDPHASE42021-12-082024-02-022024-02-02
NCT05137730A Study of Relative Bioavailability of a New Formulation Compared With the Approved Formulation of rhPTH [1-84] and to Find Out Dose Linearity of the New Formulation in Healthy AdultsCOMPLETEDPHASE12021-11-292022-04-152022-04-15
NCT05098041A Study of Soticlestat and Rifampin in Healthy AdultsCOMPLETEDPHASE12021-11-222022-03-032022-02-16
NCT04082481A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-988 in Healthy ParticipantsWITHDRAWNPHASE12021-11-172022-04-292022-04-29
NCT05020015A Study of TAK-007 in Adults With Relapsed or Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)ACTIVE_NOT_RECRUITINGPHASE22021-11-122038-12-202024-06-16
NCT04938427A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut SyndromeCOMPLETEDPHASE32021-11-082024-01-252024-01-25
NCT05098054A Study of Soticlestat in Adults With Liver Failure Compared to Those With Normal Liver FunctionCOMPLETEDPHASE12021-10-292022-06-072022-05-31
NCT04940624A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet SyndromeCOMPLETEDPHASE32021-10-282024-04-112024-04-11
NCT04779307A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)COMPLETEDPHASE32021-10-192025-07-012025-07-01
NCT05064449A Study of Soticlestat With Itraconazole and Mefenamic Acid in Healthy AdultsCOMPLETEDPHASE12021-10-142021-11-302021-11-21
NCT05059977A Study of TAK-881 in Healthy AdultsCOMPLETEDPHASE12021-10-122022-04-122022-04-12
NCT04985656A Study of Pevonedistat Combined With Decitabine and Cedazuridine in Adults With Higher-risk Myelodysplastic SyndromesWITHDRAWNPHASE22021-10-012024-11-082024-01-08
NCT05025397A Study of Danavorexton in Anesthetized AdultsCOMPLETEDPHASE12021-09-282022-03-082022-03-08
NCT04879849A Study of TAK-676 With Pembrolizumab After Radiation Therapy to Treat a Number of CancersCOMPLETEDPHASE12021-09-092024-04-302024-04-30
NCT04984889A Study of TAK-662 for Japanese Patients With Congenital Protein C DeficiencyCOMPLETEDPHASE1, PHASE22021-09-072024-10-312022-03-29
NCT04999839Study of NDI-034858 in Participants With Moderate to Severe Plaque PsoriasisCOMPLETEDPHASE22021-08-112022-09-122022-08-19
NCT04964258A Study of TAK-105 in Healthy AdultsCOMPLETEDPHASE12021-07-262023-06-202023-06-20
NCT04759833A Study of Prucalopride For Functional Constipation in Children and TeenagersTERMINATEDPHASE32021-07-132023-11-132023-11-13
NCT04701411A Study of Darvadstrocel for Treating Complex Perianal Fistulas in Children and Teenagers With Crohn's DiseaseTERMINATEDPHASE32021-06-302025-05-072025-05-07
NCT04809363A Study of CDPATHâ„¢ to Help Manage and Treat Crohn's DiseaseACTIVE_NOT_RECRUITINGPHASE42021-06-252026-06-302025-10-31
NCT04738942A Study of Intravenous Vedolizumab Administered Every 4 Weeks in Japanese Participants With Moderate to Severe Ulcerative Colitis or Crohn's DiseaseACTIVE_NOT_RECRUITINGPHASE32021-06-042027-11-302025-05-30
NCT04668157A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood PressureCOMPLETEDPHASE32021-05-172023-12-282023-12-28
NCT04313244Immunogenicity and Safety of Dengue Tetravalent Vaccine (TDV) and Recombinant 9-valent Human Papillomavirus Vaccine (9vHPV) in Participants Aged ≥9 to <15 YearsCOMPLETEDPHASE32021-05-152022-07-192022-02-21
NCT04820842A Study of TAK-994 in Adults With NarcolepsyTERMINATEDPHASE22021-04-302021-11-032021-11-03
NCT04842643An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency DiseaseCOMPLETEDPHASE32021-04-272024-04-252024-04-25
NCT04718779A Study of Enzyme Replacement Therapy (VPRIV) in People With Type 1 Gaucher Disease Who Were Previously Treated With Substrate Reduction TherapyCOMPLETEDPHASE42021-04-222023-02-162023-02-16
NCT04776018A Study Of TAK-981 Given With Monoclonal Antibodies (mAbs) In Adults With Relapsed or Refractory Multiple Myeloma (RRMM)TERMINATEDPHASE1, PHASE22021-04-202023-11-092023-08-02
NCT04683003A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic PurpuraRECRUITINGPHASE32021-04-142027-03-162027-03-16
NCT04833049Study to Evaluate Absorption, Metabolism, and Excretion, of TAK-994 in 6 Healthy Male AdultsCOMPLETEDPHASE12021-04-142021-06-202021-06-20
NCT04580407Study of TAK-672 in Participants With Acquired Hemophilia ACOMPLETEDPHASE2, PHASE32021-04-092022-11-292022-11-29
NCT04753437A Study of Vonoprazan in Adults With Helicobacter PyloriCOMPLETEDPHASE12021-04-062021-11-052021-09-27
NCT04831502Bioavailability and Food Effect Study of Two Formulations of TAK-906WITHDRAWNPHASE12021-04-022022-02-022022-02-02
NCT04844073A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic CancerACTIVE_NOT_RECRUITINGPHASE1, PHASE22021-03-082026-11-012025-09-27
NCT04440488ARALAST NP Alpha-1 Lung Density Chronic Obstructive Pulmonary Disease-Emphysema (COPD-E) StudyWITHDRAWNPHASE42021-03-082025-09-122025-09-12
NCT04501614A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaTERMINATEDPHASE1, PHASE22021-02-242024-07-192023-12-19
NCT04745767A Study of Different Forms of TAK-994 in Healthy AdultsCOMPLETEDPHASE12021-02-162021-04-052021-03-25
NCT04712110A Study of TAK-019 in Healthy Japanese Adults (COVID-19)COMPLETEDPHASE1, PHASE22021-02-122022-03-282022-03-28
NCT04687137Expanded Access Program With Lanadelumab for Japanese People With Hereditary AngioedemaCOMPLETEDPHASE32021-02-102022-06-182022-06-18
NCT04444895A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-InhibitorCOMPLETEDPHASE32021-02-052023-05-052023-05-05
NCT04731922A Study of TAK-510 in Healthy AdultsCOMPLETEDPHASE12021-02-032022-07-242022-07-24
NCT04654351A Study of Icatibant (TAK-667) in Japanese Children and Teenagers With Acute Attacks of Hereditary AngioedemaCOMPLETEDPHASE32021-01-152021-07-272021-07-27
NCT04465396A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult ParticipantsCOMPLETEDPHASE12021-01-132021-08-202021-08-20
NCT04677660A Study of TAK-919 in Healthy Japanese Adults (COVID-19)COMPLETEDPHASE1, PHASE22021-01-072022-02-222022-02-22
NCT04118088A Study of Darvadstrocel in Adults With Crohn's Disease and Complex Perianal FistulaTERMINATEDPHASE42020-12-222025-02-142025-02-14
NCT04576208A Study to Evaluate the Impact of Management Strategies on Gastrointestinal-Related Adverse Events in Participants With Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations Receiving TAK-788WITHDRAWNPHASE22020-11-302022-07-312022-07-31
NCT04278924A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune ThrombocytopeniaCOMPLETEDPHASE22020-11-092024-04-292024-04-29
NCT04460105Lanadelumab in Participants Hospitalized With COVID-19 PneumoniaWITHDRAWNPHASE12020-10-312021-01-272021-01-27
NCT03888534Intravenous Ixazomib in Pediatric Participants With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LLy)WITHDRAWNPHASE12020-10-312022-08-302022-08-30
NCT04578535A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult ParticipantsCOMPLETEDPHASE12020-10-272022-03-022022-03-02
NCT04334317A Study of TAK-071 in People With Parkinson DiseaseCOMPLETEDPHASE22020-10-212023-02-272023-02-27
NCT04557189A Study of TAK-951 to Stop Adults Getting Nausea and Vomiting After Planned SurgeryCOMPLETEDPHASE22020-10-202022-03-212022-03-07
NCT04266795A Study of Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive ChemotherapyACTIVE_NOT_RECRUITINGPHASE22020-10-132025-10-132022-09-06
NCT04056468A Study to Evaluate Pharmacokinetics (PK) and Safety of Oral Mobocertinib in Participants With Moderate or Severe Hepatic Impairment (HI) and Normal Hepatic FunctionCOMPLETEDPHASE12020-10-092022-02-262022-02-05
NCT04464460A Study to Evaluate the Safety, Pharmacokinetics (PK), and Efficacy of TAK-671 for the Treatment of Coronavirus Disease (COVID) 2019 in AdultsWITHDRAWNPHASE12020-09-252020-10-302020-10-30
NCT04551079A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics (PK) of Oral TAK-994 in an Acute Sleep Phase Delay Paradigm in Healthy Male ParticipantsCOMPLETEDPHASE12020-09-232020-12-312020-12-31
NCT04260009Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid TumorsWITHDRAWNPHASE1, PHASE22020-09-012025-09-012023-09-01
NCT04419649A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic SyndromesRECRUITINGPHASE22020-08-192030-10-302029-10-30
NCT04381650A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid TumorsCOMPLETEDPHASE1, PHASE22020-08-172024-10-292024-10-29
NCT04461483A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose and Multiple Doses With Titration of TAK-935 in Healthy Japanese ParticipantsCOMPLETEDPHASE12020-08-132020-11-142020-11-14
NCT04346108A Study of Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID)COMPLETEDPHASE32020-08-112021-12-222021-12-22
NCT04503603A Study to Determine the Safety, Tolerability, and Pharmacokinetics of Lanadelumab Administered Intravenously in Healthy Adult Volunteer ParticipantsCOMPLETEDPHASE12020-08-102020-12-232020-12-23
NCT04497883A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Maribavir Administered in Healthy Japanese Participants Compared With Matched, Healthy, Non-Hispanic, Caucasian Participants and to Assess Dose-Proportionality of 3 Doses of Maribavir in Japanese ParticipantsCOMPLETEDPHASE12020-08-072020-11-122020-11-12
NCT03943446A Study of TAK-018 in Preventing the Recurrence of Crohn's Disease After SurgeryTERMINATEDPHASE22020-08-042022-08-252022-08-25
NCT04454918Study to Assess Absolute Bioavailability (ABA) of TAK-906 and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of [14C]-TAK-906 in Healthy Male ParticipantsCOMPLETEDPHASE12020-07-302020-09-302020-09-30
NCT04420884A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid TumorsACTIVE_NOT_RECRUITINGPHASE1, PHASE22020-07-222026-03-312026-03-31
NCT04405778A Study of TAK-102 in Adult With Previously-Treated Solid TumorsTERMINATEDPHASE12020-07-102025-05-092025-05-09
NCT04992442Study to Assess Absolute Bioavailability of TAK-935 (OV935) and to Characterize Mass Balance, Pharmacokinetics, Metabolism, and Excretion of [14C]TAK-935 (OV935) in Healthy Male ParticipantsCOMPLETEDPHASE12020-07-092020-08-182020-08-18
NCT04486950A Study of TAK-951 in Healthy AdultsCOMPLETEDPHASE12020-07-072021-05-272021-05-16
NCT04441255A Study to Evaluate the Effect of High-Fat Meal on TAK-788 Pharmacokinetics (PK) in Healthy Adult ParticipantsCOMPLETEDPHASE12020-07-012020-08-102020-08-10
NCT04392648A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)WITHDRAWNPHASE12020-06-242023-11-102023-11-10
NCT04096560A Study of TAK-994 in Adults With Type 1 and Type 2 NarcolepsyTERMINATEDPHASE22020-05-272021-11-052021-11-05
NCT04394286A Phase 1/2 Study of SHP648, an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia B SubjectsTERMINATEDPHASE1, PHASE22020-05-132021-05-032021-05-03
NCT04206605A Study of Lanadelumab in Teenagers and Adults to Prevent Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH)COMPLETEDPHASE32020-05-042022-10-202022-10-20
NCT04198363A Study to Evaluate the Efficacy and Safety of Bismuth-Containing Quadruple Therapy With Oral Vonoprazan (TAK-438) 20 mg Compared to Esomeprazole 20 mg Twice Daily in Paticipants With Helicobacter Pylori InfectionCOMPLETEDPHASE32020-04-302021-11-252021-11-01
NCT04056455A Study of Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy KidneysCOMPLETEDPHASE12020-03-042022-04-202022-04-20
NCT04091438A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic HypersomniaCOMPLETEDPHASE12020-01-262020-11-232020-11-19
NCT04159805A Study of TAK-079 in People With Generalized Myasthenia GravisCOMPLETEDPHASE22020-01-142022-07-122022-07-12
NCT04129502TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy for Non-Small Cell Lung Cancer (NSCLC) With EGFR Exon 20 Insertion MutationsACTIVE_NOT_RECRUITINGPHASE32020-01-102026-10-312026-10-31
NCT04051827Drug-Drug Interaction Study of TAK-788 and Midazolam in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)COMPLETEDPHASE12019-12-232021-12-072020-12-17
NCT04202497A Study With [18F]MNI-1054 to Determine Lysine -Specific Demethylase 1A (LSD1) Brain Enzyme Occupancy of TAK-418 After Single-Dose Oral Administration in Healthy ParticipantsTERMINATEDPHASE12019-12-182020-03-192020-03-05
NCT04157517A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid TumorsTERMINATEDPHASE1, PHASE22019-12-122023-12-202023-12-20
NCT04180163Efficacy and Safety of Lanadelumab (SHP643) in Japanese Participants With Hereditary Angioedema (HAE)COMPLETEDPHASE32019-12-122021-08-262021-08-26
NCT04091425Study of TAK-925 in Participants With Obstructive Sleep Apnea (OSA) Who Are Experiencing Excessive Daytime Sleepiness (EDS) Despite Adequate Use of Continuous Positive Airway Pressure (CPAP)COMPLETEDPHASE12019-11-212020-04-022020-04-02
NCT04155567A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-123 After Intravenous Infusion in Japanese Healthy Adult Male ParticipantsCOMPLETEDPHASE12019-11-132019-12-062019-12-06
NCT03999996Long-Term Safety and Antibody Persistence of TDV and the Impact of a Booster DoseCOMPLETEDPHASE32019-11-122024-05-252024-05-25
NCT04075825Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal FistulaCOMPLETEDPHASE32019-11-052024-04-022024-04-02
NCT04131556A Study Comparing the Pharmacokinetics and Palatability of Two Candidate Pediatric Powder-for-Oral-Suspension Formulations of Maribavir to the Current Maribavir Tablet Formulation Administered in Healthy Adult ParticipantsTERMINATEDPHASE12019-10-252020-01-062020-01-06
NCT03997760A Study of SHP655 (rADAMTS13) in Sickle Cell DiseaseCOMPLETEDPHASE12019-10-212022-10-262022-10-26
NCT04074330A Study of TAK-981 Given With Rituximab in Adults With Relapsed or Refractory CD20-Positive Non-Hodgkin LymphomaTERMINATEDPHASE1, PHASE22019-10-152023-04-262023-04-26
NCT04121078A Study to Evaluate the Effect of Single-Dose Intravenous Rifampin as a Prototypic Inhibitor of Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 on the Single-Dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult ParticipantsCOMPLETEDPHASE12019-10-152019-11-162019-11-04
NCT03922308Study of rADAMTS-13 (SHP655) in the Treatment of Participants With Acquired Thrombotic Thrombocytopenic Purpura (aTTP)COMPLETEDPHASE22019-10-092021-08-052021-08-05
NCT03608501A Study of Ixazomib, Thalidomide and Dexamethasone in Newly Diagnosed and Treatment-naive Multiple Myeloma (MM) Participants Non-eligible for Autologous Stem-cell TransplantationWITHDRAWNPHASE22019-09-302023-05-312021-06-30
NCT04085172A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)COMPLETEDPHASE42019-09-182025-09-022025-09-02
NCT04070326A Study of Lanadelumab to Prevent Hereditary Angioedema (HAE) Attacks in ChildrenCOMPLETEDPHASE32019-08-192021-10-302021-10-30
NCT03984097A Study to Evaluate Subcutaneous TAK-079 Added to Standard of Care Regimens in Participants With Newly Diagnosed Multiple Myeloma (NDMM)ACTIVE_NOT_RECRUITINGPHASE12019-07-292026-03-312026-03-31
NCT03990649Study of TAK-935 as an Adjunctive Therapy in Adult Participants With Complex Regional Pain Syndrome (CRPS)COMPLETEDPHASE22019-07-232020-10-282020-06-29
NCT03814005A Study of Pevonedistat in People With Blood Cancers or Solid Tumors With Kidney or Liver ProblemsCOMPLETEDPHASE12019-07-102022-04-192021-03-19
NCT03420742A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate, Midazolam, in Participants With ALK-Positive or ROS1-Positive Solid TumorsCOMPLETEDPHASE12019-06-262021-04-292020-03-24
NCT03918239A Study to Determine the Bioavailability of Lanadelumab (SHP643) Administered Subcutaneously With the Prefilled Syringe and the Autoinjector in Healthy Adult Volunteer Participants.COMPLETEDPHASE12019-05-142019-11-132019-11-13
NCT03771898A Study of Intrathecal SHP611 in Children With Metachromatic LeukodystrophyACTIVE_NOT_RECRUITINGPHASE22019-05-132025-10-312023-03-08
NCT03928327A Study to Evaluate Drug-Drug Interaction of TAK-788 With Itraconazole and Rifampin in Healthy Adult ParticipantsCOMPLETEDPHASE12019-05-022019-08-162019-08-16
NCT03933488A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Healthy ParticipantsCOMPLETEDPHASE12019-05-012020-03-292020-03-29
NCT03596866A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung CancerCOMPLETEDPHASE32019-04-192024-09-182024-02-27
NCT03879135A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD)COMPLETEDPHASE32019-04-012025-01-302025-01-30
NCT03771963Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) at the End of Shelf Life in Healthy AdultsCOMPLETEDPHASE32019-03-282020-03-132019-10-14
NCT03708211A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid TumorsCOMPLETEDPHASE12019-03-282019-12-032019-12-03
NCT03859323A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Ascending, Subcutaneous, Single and Multiple Doses of SHP681 (Glucagon-like Peptide-2 [GLP-2] Analog-Fc Fusion) in Healthy Adult ParticipantsCOMPLETEDPHASE12019-03-262020-01-062020-01-06
NCT03870555A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-954 in Healthy Adult ParticipantsCOMPLETEDPHASE12019-03-082019-05-162019-05-16
NCT03827655A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After SurgeryCOMPLETEDPHASE22019-03-072022-05-272022-05-27
NCT05567393A Study of TAK-951 in Healthy AdultsCOMPLETEDPHASE12019-03-072020-11-022020-11-02
NCT03706456Phase 3 Study of Cx601 in Participants With Complex Perianal Fistulising Crohn's DiseaseCOMPLETEDPHASE32019-03-062023-02-102020-07-20
NCT03849690A Trial to Evaluate the Effect of the Proton Pump Inhibitor Esomeprazole on the Single-dose Pharmacokinetics (PK) of Oral TAK-906 in Healthy Adult ParticipantsCOMPLETEDPHASE12019-02-272019-04-152019-04-15
NCT03866434Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of SPD422 (Anagrelide Hydrochloride) in Healthy Adult ParticipantsCOMPLETEDPHASE12019-02-262019-04-102019-04-10
NCT02764489FEIBA Reconstitution Volume Reduction and Faster Infusion Study (FEIBA STAR)COMPLETEDPHASE32019-02-122021-12-272021-12-27
NCT03657160Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) TransplantationCOMPLETEDPHASE32019-02-062022-05-092022-02-07
NCT03627091Efficacy and Safety Study of Ontamalimab as Maintenance Treatment in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 307)TERMINATEDPHASE32019-02-062021-09-132021-06-21
NCT03807778A Study of Mobocertinib in Japanese Adults With Non-Small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE12019-02-042026-09-302021-11-08
NCT03535740A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or CeritinibCOMPLETEDPHASE22019-01-312024-08-212020-09-30
NCT03808493A Bioequivalence (BE) Study of TAK-438 Orally Disintegrating (OD) TabletCOMPLETEDPHASE12019-01-302019-03-122019-03-12
NCT03748953Study of Oral Ixazomib Maintenance Therapy After Initial Therapy in Participants With Newly Diagnosed Multiple Myeloma Not Treated With Stem Cell Transplantation (SCT)COMPLETEDPHASE32019-01-242023-12-062023-12-06
NCT03811834A Study to Assess Absolute Bioavailability (ABA) of Mobocertinib (TAK-788) and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of Carbon-14 ([14C])-Mobocertinib in Male Healthy ParticipantsCOMPLETEDPHASE12019-01-222019-03-112019-03-11
NCT03801148A Study to Compare the Bioavailability (BA) of Dexlansoprazole Delayed-release CapsulesCOMPLETEDPHASE12019-01-102019-04-092019-02-25
NCT03746015Immunogenicity and Safety of Tetravalent Dengue Vaccine Candidate (TDV) in Flavivirus-Naïve and Dengue-Immune AdultsCOMPLETEDPHASE22018-12-282021-03-012021-03-01
NCT03759587Japan Phase 2 Study of Niraparib (Maintenance Therapy) in Participants With Relapsed Ovarian CancerCOMPLETEDPHASE22018-12-282022-12-282019-03-17
NCT03759600Japan Phase 2 Study of Niraparib in Participants With Advanced, Relapsed Ovarian CancerCOMPLETEDPHASE22018-12-262022-12-282022-12-28
NCT03565237RIXUBIS PMS India (RIXUBIS PMS)COMPLETEDPHASE42018-12-072021-08-112021-08-11
NCT03724916A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)COMPLETEDPHASE12018-11-262021-11-042021-11-04
NCT03748979A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With NarcolepsyCOMPLETEDPHASE12018-11-212019-10-242019-10-24
NCT03738475Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac DiseaseCOMPLETEDPHASE22018-11-112019-07-222019-06-24
NCT03544229A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic GastroparesisCOMPLETEDPHASE22018-10-142021-07-152021-06-14
NCT03589326A Study of Ponatinib Versus Imatinib in Adults With Acute Lymphoblastic LeukemiaACTIVE_NOT_RECRUITINGPHASE32018-10-042027-07-312022-08-12
NCT03648372A Study of TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune SystemTERMINATEDPHASE1, PHASE22018-10-012023-12-142023-11-22
NCT03364738Safety and Efficacy Study of rhPTH(1-84) in Subjects With HypoparathyroidismTERMINATEDPHASE32018-09-262020-04-142020-04-14
NCT03694275A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)COMPLETEDPHASE22018-09-102020-07-312020-07-13
NCT03571516Safety, Efficacy and Pharmacokinetic Study of Teduglutide in Infants 4 to 12 Months of Age With Short Bowel SyndromeCOMPLETEDPHASE32018-08-312020-09-242020-09-24
NCT03559517Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)TERMINATEDPHASE32018-08-292020-10-082020-07-07
NCT03477903TAK-954 in Critically Ill Participants With Enteral Feeding Intolerance (EFI)TERMINATEDPHASE22018-08-252018-08-292018-08-29
NCT03486314A Study to Evaluate the Effects of Rifampin on Pharmacokinetics (PK) of Pevonedistat in Participants With Advanced Solid TumorsCOMPLETEDPHASE12018-08-132021-02-282019-05-10
NCT03650452A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic EncephalopathiesCOMPLETEDPHASE22018-08-082020-07-202020-06-09
NCT03586973A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Hepatocellular CarcinomaCOMPLETEDPHASE22018-08-062021-06-292019-07-17
NCT03196427Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)COMPLETEDPHASE22018-07-302025-07-172025-04-03
NCT03635073A Study of Soticlestat in Adults and Children With Rare EpilepsiesTERMINATEDPHASE22018-07-192025-07-302025-07-30
NCT03566823Efficacy and Safety Study of Ontamalimab as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 306)TERMINATEDPHASE32018-07-172020-08-182020-08-18
NCT03596164An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004COMPLETEDPHASE32018-07-092022-01-132022-01-13
NCT03663582Study of Teduglutide in Japanese Participants With Short Bowel SyndromeCOMPLETEDPHASE32018-07-062019-08-062019-08-06
NCT03701555A Study of PVP001, PVP002, and PVP003 in Healthy Adults and PVP001 and PVP002 in Adults With Celiac DiseaseCOMPLETEDPHASE12018-06-192021-07-022021-01-31
NCT03501069A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Multiple Oral Dose of TAK-418 in Healthy Female ParticipantsTERMINATEDPHASE12018-05-302018-12-262018-12-26
NCT03501277A Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian ParticipantsCOMPLETEDPHASE12018-05-262018-07-112018-07-11
NCT03525119Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Co-administered With an Hepatitis A Virus VaccineCOMPLETEDPHASE32018-05-162019-07-092018-10-03
NCT03522506A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy AdultsCOMPLETEDPHASE12018-05-092018-11-072018-11-07
NCT03469349Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIBCOMPLETEDPHASE32018-05-012019-08-282019-05-28
NCT03500224A Study to Evaluate the Mass Balance, Pharmacokinetics (PK), Metabolism and Excretion of TAK-954 Containing Microtracer ([14C]-TAK-954) in Healthy Male ParticipantsCOMPLETEDPHASE12018-04-302018-06-012018-06-01
NCT03409796Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten ChallengeCOMPLETEDNA2018-04-242019-05-022019-05-02
NCT03336450Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Pediatric Patients With Status Epilepticus (Convulsive) in the Community SettingCOMPLETEDPHASE32018-04-232020-10-132020-10-13
NCT03449030A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC)TERMINATEDPHASE12018-04-232020-02-272020-02-27
NCT03439280A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)COMPLETEDPHASE1, PHASE22018-04-202022-01-282022-01-28
NCT03497429A Study of Niraparib as Single Agent in Participants With Advanced Solid TumorsCOMPLETEDPHASE12018-04-052020-02-102020-02-10
NCT03290781An Efficacy and Safety Study of Ontamalimab as Maintenance Therapy in Participants With Moderate to Severe Ulcerative ColitisCOMPLETEDPHASE32018-04-042021-07-012021-07-01
NCT03482453A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-788 Followed by Evaluation of the Effects of a Low-Fat Meal on TAK-788 PK and Evaluation of Relative Bioavailability of TAK-788 Capsules in Healthy ParticipantsCOMPLETEDPHASE12018-03-282019-01-182018-12-22
NCT03439293A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)COMPLETEDPHASE22018-03-132023-06-262022-01-01
NCT03327402Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE12018-03-132018-10-052018-10-05
NCT03961308A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy ParticipantsCOMPLETEDPHASE12018-03-122018-11-212018-10-20
NCT03456960A Study to Evaluate the Bioequivalence (BE) and the Food Effect of TAK-438ASA TabletCOMPLETEDPHASE12018-03-082018-10-122018-10-10
NCT03329209A Study to Determine the Pharmacokinetics (PK) of Single Intravenous (IV) Dose of Vedolizumab 300 Milligram (mg) in Healthy Adult Chinese ParticipantsCOMPLETEDPHASE12018-03-052018-09-052018-07-26
NCT03342898Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in AdultsCOMPLETEDPHASE32018-02-282019-05-222018-05-09
NCT03370172A Study of BAX 888 in Male Adults With Severe Hemophilia ACOMPLETEDPHASE1, PHASE22018-02-272024-07-092024-07-09
NCT03283085A Safety Extension Study of Ontamalimab in Participants With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)COMPLETEDPHASE32018-02-272023-12-132023-12-13
NCT03961295A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Autoinjector (PFS+AI) in Healthy ParticipantsCOMPLETEDPHASE12018-02-222018-08-282018-07-14
NCT03948581A Pilot Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy ParticipantsCOMPLETEDPHASE12018-02-212018-09-212018-08-14
NCT03416374A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Initially Treated With an Injection of Proteasome Inhibitor-Based TherapyCOMPLETEDPHASE42018-02-182021-05-282021-05-28
NCT03437564A Bioequivalence Study of the Lu AA21004 20 mg and 2×10 mg TabletsCOMPLETEDPHASE12018-02-162018-04-132018-04-13
NCT03312894Efficacy and Safety of TAK-653 in Treatment-Resistant DepressionWITHDRAWNPHASE22018-02-152019-09-302019-02-28
NCT03434977A Phase 1 Food Effect Study of Azilsartan (TAK-536) Pediatric FormulationCOMPLETEDPHASE12018-02-142018-03-112018-03-11
NCT03423173Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for DengueCOMPLETEDPHASE32018-02-122019-01-142018-08-03
NCT03259334Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative ColitisTERMINATEDPHASE32018-02-092020-10-232020-07-22
NCT03949621A Study to Compare the Pharmacokinetics (PK) of Single Subcutaneous (SC) Injections of Vedolizumab Administered in Prefilled Syringe (PFS) Versus (vs) Prefilled Syringe in Needle Safety Device (PFS+NSD) in Healthy ParticipantsCOMPLETEDPHASE12018-02-062018-08-132018-07-02
NCT03410108Phase 2 Study of Brigatinib in Japanese Participants With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC)COMPLETEDPHASE22018-01-292021-07-282020-09-29
NCT03324880A Study to Learn if Recombinant Human Parathyroid Hormone [rhPTH(1-84)] Can Improve Symptoms and Metabolic Control in Adults With Hypoparathyroidism (BALANCE)COMPLETEDPHASE42018-01-242022-05-192022-05-19
NCT03486990Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac DiseaseCOMPLETEDPHASE12018-01-232019-07-222019-05-24
NCT03401671Study of Lanadelumab in Healthy Japanese and Matched Caucasian Adult SubjectsCOMPLETEDPHASE12018-01-152018-05-302018-05-30
NCT03370289A Phase 4 Post-marketing Study of Intramuscular Injections of BLB-750 in Healthy Adult SubjectsCOMPLETEDPHASE42018-01-122018-02-282018-02-28
NCT03325894Safety and Tolerability Study of SHP465 in Children Aged 4 to 12 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)TERMINATEDPHASE32018-01-022019-01-192019-01-19
NCT03281577Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis ParticipantsCOMPLETEDPHASE22018-01-022019-07-122019-06-07
NCT03341637Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s)COMPLETEDPHASE32017-12-142019-01-262019-01-26
NCT03339219A Phase 2 Study of Cabozantinib in Japanese Participants With Advanced Renal Cell CarcinomaCOMPLETEDPHASE22017-12-132020-08-252020-08-25
NCT03325881Efficacy and Safety of SHP465 at 6.25 mg in the Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-12 YearsCOMPLETEDPHASE32017-12-092018-06-072018-06-07
NCT03259308Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative ColitisTERMINATEDPHASE32017-12-052020-10-062020-07-15
NCT02559713Postmarketing Vedolizumab Milk-Only Lactation Study in Lactating Women With Active Ulcerative Colitis or Crohn's DiseaseCOMPLETEDPHASE42017-11-292019-02-222019-02-22
NCT03268954Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)COMPLETEDPHASE32017-11-282024-10-142021-05-28
NCT03316976A Study to Evaluate the Pharmacokinetics of Dexlansoprazole 30 Milligram (mg) and 60 mg Delayed-release Capsules in Healthy Chinese ParticipantsCOMPLETEDPHASE12017-11-222018-02-082018-02-08
NCT03296787A Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics (PK) of a Single Intravenous (IV) TAK-954COMPLETEDPHASE12017-11-212019-08-092019-08-09
NCT02973087rVWF IN PROPHYLAXISCOMPLETEDPHASE32017-11-162020-07-062020-07-06
NCT03330106A Study to Evaluate the Effects of Pevonedistat on the Corrected QT (QTc) Interval in Participants With Advanced Solid TumorsCOMPLETEDPHASE12017-11-152021-06-212019-01-07
NCT03173092A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)ACTIVE_NOT_RECRUITINGPHASE42017-11-132026-11-302026-11-30
NCT03343626Safety, Immunogenicity, and Dose Ranging Study of Inactivated Zika Virus Vaccine in Healthy ParticipantsCOMPLETEDPHASE12017-11-132020-11-242018-12-28
NCT03277274A Study to Evaluate the Effect of Hepatic Impairment on the Single Dose Pharmacokinetics (PK) of Intravenous TAK-954COMPLETEDPHASE12017-11-092018-09-102018-09-01
NCT03138655Vedolizumab IV in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD)COMPLETEDPHASE22017-11-082020-05-262020-03-31
NCT02932618A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)RECRUITINGPHASE32017-11-062026-03-312026-03-31
NCT03332784Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With NarcolepsyCOMPLETEDPHASE12017-11-042018-09-042018-09-04
NCT03261947A Study to Evaluate the Safety, Tolerability, and Activity of TAK-931 in Participants With Metastatic Pancreatic Cancer, Metastatic Colorectal Cancer, and Other Advanced Solid TumorsCOMPLETEDPHASE22017-10-252020-08-242020-08-24
NCT03336645Open-label Study of Midazolam Hydrochloride Oromucosal Solution (MHOS/SHP615) in Children With Status Epilepticus (Convulsive) in a Healthcare Setting in JapanCOMPLETEDPHASE32017-10-232019-08-192019-08-19
NCT03393975A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP)COMPLETEDPHASE32017-10-132024-05-302023-12-28
NCT03245840Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Participants With Eosinophilic Esophagitis (EoE)TERMINATEDPHASE32017-10-052022-04-262022-04-26
NCT03215030A Study of Modakafusp Alfa on Adult Participants With Relapsed/Refractory Multiple MyelomaCOMPLETEDPHASE1, PHASE22017-10-042024-11-072024-07-01
NCT03268941A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG)COMPLETEDPHASE22017-09-262018-03-092018-03-09
NCT03277313Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD SubjectsCOMPLETEDPHASE32017-09-252022-07-202022-07-20
NCT03279081Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD)COMPLETEDPHASE32017-09-152023-07-262023-01-23
NCT02979522A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin LymphomaACTIVE_NOT_RECRUITINGPHASE1, PHASE22017-09-062029-09-242020-05-05
NCT03260205Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE32017-09-062018-10-232018-10-23
NCT03268811A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302COMPLETEDPHASE32017-08-232021-11-022021-11-02
NCT03231709Treatment Preference for Weekly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Versus Daily DPP-4 Inhibitors in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE42017-08-182018-02-092018-02-09
NCT03166215Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic EncephalopathiesCOMPLETEDPHASE1, PHASE22017-08-172018-09-192018-09-19
NCT03237156Phase 1 TAK-906 Single and Multiple Ascending Dose Study in Japanese Healthy Male ParticipantsCOMPLETEDPHASE12017-08-072017-10-072017-10-07
NCT03221036Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative ColitisRECRUITINGPHASE32017-08-032028-07-182028-05-23
NCT03234907Vedolizumab Intravenous (IV) Compared to Placebo in Chinese Participants With Crohn's Disease.COMPLETEDPHASE32017-08-032020-08-142020-08-14
NCT03116841Vonoprazan Study of Investigating the Effect on Sleep Disturbance Associated With Reflux Esophagitis- Exploratory EvaluationCOMPLETEDPHASE42017-08-022017-12-202017-12-20
NCT03170882A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple MyelomaCOMPLETEDPHASE22017-08-012021-11-262020-08-01
NCT03042325Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes MellitusWITHDRAWNPHASE42017-07-302018-01-152018-01-15
NCT03228433A Study to Evaluate Safety, Tolerability and Pharmacokinetics of Ascending Oral Single Dose of TAK-418 in Healthy ParticipantsCOMPLETEDPHASE12017-07-212018-05-122018-05-12
NCT03092791IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and AdultsTERMINATEDPHASE1, PHASE22017-06-072018-10-182018-04-03
NCT03161405A Study to Evaluate the Effect of the Potent CYP3A4 Inhibitor Itraconazole on the Pharmacokinetics (PK) of TAK-906 in Healthy ParticipantsCOMPLETEDPHASE12017-06-052017-07-102017-07-02
NCT03173170A Study to Evaluate the Effect of the Potent Cytochrome P-450 3A4 (CYP3A4) Inhibitor Itraconazole on the Pharmacokinetics (PK) of TAK-954 in Healthy Adult ParticipantsCOMPLETEDPHASE12017-05-312017-07-242017-07-24
NCT03116347Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD SubjectsCOMPLETEDPHASE42017-05-302021-01-152021-01-15
NCT03150108Study of rhPTH(1-84) in Japanese Healthy Subjects Compared With Matched Caucasian Healthy Adult SubjectsCOMPLETEDPHASE12017-05-162017-06-262017-06-26
NCT03057366A Study of [14 C]-Pevonedistat in Participants With Advanced Solid TumorsCOMPLETEDPHASE12017-05-112018-11-052018-02-08
NCT03131167Study of SHP639 Eye Drops in Adults With High Eye Pressure or Primary Open-angle GlaucomaCOMPLETEDPHASE12017-05-102018-05-302018-05-30
NCT02669082The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using ActigraphyCOMPLETEDPHASE42017-05-092018-01-312018-01-31
NCT02969265An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential HypertensionWITHDRAWNPHASE32017-05-092018-07-262018-07-12
NCT02993783A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)TERMINATEDPHASE22017-04-282018-05-092018-05-09
NCT02956122A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHDTERMINATEDPHASE2, PHASE32017-04-262018-05-032018-05-03
NCT03131895Bioequivalence Study of Dexlansoprazole Capsules From Two Manufacturing PlantsCOMPLETEDPHASE12017-04-252017-07-312017-07-03
NCT03085836A Pharmacokinetic Study of TAK-438 in Healthy Adult Chinese ParticipantsCOMPLETEDPHASE12017-04-192017-08-172017-08-17
NCT02764762Triple Combination Therapy in High Risk Crohn's Disease (CD)COMPLETEDPHASE42017-04-182022-07-052020-09-22
NCT03050307Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori InfectionCOMPLETEDPHASE32017-04-172020-05-262020-02-19
NCT02927067A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell TransplantsCOMPLETEDPHASE32017-04-142022-07-012022-07-01
NCT03050359Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori InfectionCOMPLETEDPHASE32017-04-052019-07-192019-03-19
NCT02948829Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy ChildrenCOMPLETEDPHASE22017-04-032020-12-142017-10-16
NCT02781844Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With HypoparathyroidismCOMPLETEDPHASE12017-04-032019-03-082019-03-08
NCT03029143Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative ColitisCOMPLETEDPHASE42017-03-292020-10-162020-10-16
NCT03004924Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and PlaceboCOMPLETEDPHASE32017-03-292018-10-012018-10-01
NCT02998554Treatment of Adenoviral Conjunctivitis With SHP640 Compared to PlaceboTERMINATEDPHASE32017-03-282019-05-162019-05-16
NCT02998541Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and PlaceboTERMINATEDPHASE32017-03-272019-05-132019-05-13
NCT03083639A Study to Evaluate the Bioequivalence of Single Oral Dose of Esomeprazole Capsule and Tablet Formulation in Healthy ParticipantsCOMPLETEDPHASE12017-03-272017-05-132017-05-13
NCT02954406A Study of TAK-659 in Combination With Bendamustine (+/-Rituximab), Gemcitabine, Lenalidomide, or Ibrutinib for the Treatment of Participants With Advanced Non-Hodgkin LymphomaTERMINATEDPHASE12017-03-052020-07-272020-07-27
NCT03039790Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in AdultsCOMPLETEDPHASE22017-02-212021-07-222021-07-22
NCT03014479Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE42017-02-182017-10-212017-10-21
NCT03042299A Phase 1, Bio-equivalence Study of TAK-536 Pediatric FormulationCOMPLETEDPHASE12017-02-102017-03-112017-03-11
NCT03035058Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel DiseaseWITHDRAWNPHASE32017-022021-012020-09
NCT03158727Cx611-0204 SEPCELL StudyCOMPLETEDPHASE1, PHASE22017-01-302020-07-072020-07-07
NCT02980666Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral SupportCOMPLETEDPHASE32017-01-132020-01-212020-01-21
NCT02954458Long-term Safety and Efficacy Study of Teduglutide in Pediatric Participants With Short Bowel Syndrome (SBS)COMPLETEDPHASE32017-01-092020-11-052020-11-05
NCT02873689Efficacy and Safety of Dexlansoprazole on Heartburn Relief in Chinese PatientsCOMPLETEDPHASE32016-12-272018-04-192018-03-14
NCT02839902Exploratory Study of the Effects of Omega-3-acid Ethyl Esters on the Lipid and Lipoprotein Profile in the BloodCOMPLETEDPHASE42016-12-272017-08-302017-08-30
NCT02895945BAX 802 in CHA With InhibitorsTERMINATEDPHASE32016-12-222021-01-222021-01-22
NCT02931539Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or CidofovirCOMPLETEDPHASE32016-12-222020-08-172020-08-17
NCT02972632Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive DisorderCOMPLETEDPHASE42016-12-222018-02-062018-02-06
NCT02873702Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive EsophagitisTERMINATEDPHASE32016-12-212017-11-062017-10-16
NCT02924272Ixazomib Rollover StudyCOMPLETEDPHASE22016-12-162024-07-032024-07-03
NCT02949362Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 StudyCOMPLETEDPHASE32016-12-092020-07-142020-07-14
NCT02918266TAK-071 Scopolamine-Induced Cognitive Impairment StudyTERMINATEDPHASE12016-11-212017-08-082017-08-02
NCT02932904Effect of Vortioxetine, Paroxetine, and Placebo on Sexual Functioning in Healthy VolunteersCOMPLETEDPHASE42016-11-212017-06-092017-05-31
NCT02954848Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)COMPLETEDPHASE32016-11-152018-02-262018-02-25
NCT02955355Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDPCOMPLETEDPHASE32016-11-142023-07-042023-07-04
NCT02939014Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)COMPLETEDPHASE22016-11-072020-02-032018-08-02
NCT02722304Stage 1 Study of ARALAST NP and GLASSIA in A1PI DeficiencyTERMINATEDPHASE32016-11-022018-09-142018-09-14
NCT02917941A Study of Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Participants With Relapsed and/or Refractory Multiple MyelomaCOMPLETEDPHASE22016-11-012019-08-312019-08-31
NCT02760615Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction StudyWITHDRAWNPHASE42016-11-012020-08-012020-08-01
NCT02910466A Study of Extended Use of Recombinant Human Parathyroid Hormone (rhPTH(1-84)) in HypoparathyroidismCOMPLETEDPHASE42016-10-272019-12-202019-12-20
NCT02856113Phase 3 Alogliptin Pediatric StudyCOMPLETEDPHASE32016-10-142022-02-142021-08-06
NCT02790138A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic PouchitisCOMPLETEDPHASE42016-10-122021-02-022020-06-11
NCT02814565Cyclobenzaprine HCl Extended Release 15 mg Versus Placebo in Treatment of Cervical and/or Lower Back Pain Due to Muscle Spasms of Local OriginCOMPLETEDPHASE32016-10-122017-03-142017-02-10
NCT02906813A Study to Determine the Bioavailability and Food Effect of a Single TAK-935 Dose in Healthy ParticipantsCOMPLETEDPHASE12016-09-122016-11-092016-10-12
NCT02771093An Exploratory Study of the Effects of Trelagliptin and Alogliptin on Glucose Variability in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE42016-09-082017-04-272017-04-27
NCT02865720Study of C1 Inhibitor (Human) for the Prevention of Angioedema Attacks and Treatment of Breakthrough Attacks in Japanese Subjects With Hereditary Angioedema (HAE)COMPLETEDPHASE32016-09-082017-06-232017-06-23
NCT02747927Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy ChildrenACTIVE_NOT_RECRUITINGPHASE32016-09-072024-08-122018-07-11
NCT02892409TAK-438 Bismuth Drug Interaction StudyCOMPLETEDPHASE12016-09-052017-05-112017-04-17
NCT02791438A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With HypertensionCOMPLETEDPHASE32016-08-182019-06-042019-06-04
NCT02630966Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's DiseaseCOMPLETEDPHASE42016-08-102018-11-142018-09-04
NCT02824432Exploratory Study of the Effect of Omega-3-acid Ethyl Esters (TAK-085) on Vascular Endothelial Function in Patients With Hyperlipidemia by Flow Mediated DilationCOMPLETEDPHASE42016-08-042017-08-192017-08-19
NCT02743806Extended Access Program of Vedolizumab IV in Ulcerative Colitis and Crohn's DiseaseTERMINATEDPHASE42016-08-012023-01-032023-01-03
NCT02775240Study of SHP620 (Maribavir) in Healthy AdultsCOMPLETEDPHASE12016-07-212016-09-122016-09-12
NCT02743949Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)COMPLETEDPHASE22016-07-142018-10-122018-10-05
NCT02792062A Food Effect Study of TAK-385 Final FormulationCOMPLETEDPHASE12016-07-042016-08-312016-08-31
NCT02724020MLN0128 and MLN0128 + MLN1117 Compared With Everolimus in the Treatment of Adults With Advanced or Metastatic Clear-Cell Renal Cell CarcinomaCOMPLETEDPHASE22016-06-302020-10-132020-02-03
NCT02817516A Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of TAK-828 Escalating Multiple-Doses in Healthy ParticipantsTERMINATEDPHASE12016-06-302016-08-222016-08-22
NCT02574286Study of the Effect of Velaglucerase Alfa (VPRIV®) on Bone-related Pathology in Treatment-naïve Participants With Type 1 Gaucher DiseaseCOMPLETEDPHASE42016-06-292020-11-302020-11-12
NCT02682381Short Bowel Syndrome Research Study for Children Up To 17 Years of Age on Parenteral NutritionCOMPLETEDPHASE32016-06-232017-08-182017-08-18
NCT02723006Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced MelanomaTERMINATEDPHASE12016-06-222018-05-112018-05-11
NCT02716116A Study of TAK-788 in Adults With Non-Small Cell Lung CancerACTIVE_NOT_RECRUITINGPHASE1, PHASE22016-06-162026-10-312026-10-31
NCT02728895Dose Finding Study of Vedolizumab for GvHD in Participants Undergoing Allogeneic HSCTCOMPLETEDPHASE12016-06-152018-07-102018-07-10
NCT02669121Efficacy and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-like Particle Vaccine in AdultsCOMPLETEDPHASE22016-06-142018-06-162018-06-16
NCT02737501ALTA-1L Study: A Study of Brigatinib Versus Crizotinib in Anaplastic Lymphoma Kinase Positive (ALK+) Advanced Non-small Cell Lung Cancer (NSCLC) ParticipantsCOMPLETEDPHASE32016-05-262021-01-292020-07-28
NCT02741596Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAECOMPLETEDPHASE32016-05-262019-10-312019-10-31
NCT02547220A Multicenter Study to Evaluate the Efficacy and Safety of Cinryze® for the Treatment of Acute Antibody-mediated Rejection in Participants With Kidney TransplantTERMINATEDPHASE32016-05-202019-05-312019-05-31
NCT02782468A Study of Pevonedistat in Adult East Asian ParticipantsCOMPLETEDPHASE12016-05-162022-01-252022-01-25
NCT02729909Lubiprostone for Chronic Idiopathic Constipation TreatmentCOMPLETEDPHASE32016-05-112017-06-052017-04-28
NCT02769065Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy ParticipantsTERMINATEDPHASE12016-05-052017-06-082017-06-08
NCT02723201TAK-020 Relative Bioavailability and Food Effect Study in Healthy ParticipantsCOMPLETEDPHASE12016-04-282016-08-242016-08-05
NCT02620046A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's DiseaseCOMPLETEDPHASE32016-04-152024-06-122024-06-12
NCT02610777An Efficacy and Safety Study of Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine in Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML) and Low-Blast Acute Myelogenous Leukemia (AML)COMPLETEDPHASE22016-04-142021-07-232019-09-04
NCT02695719Lubiprostone for Treatment of Chronic Idiopathic ConstipationCOMPLETEDPHASE32016-04-142017-02-242017-01-20
NCT02725268A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial CancerCOMPLETEDPHASE22016-04-012020-10-302019-07-02
NCT02736409An Extension Study to Evaluate Maintenance of Efficacy and Long-term Treatment Effect of Oral Budesonide Suspension (OBS) in Adults and Adolescents With Eosinophilic Esophagitis (EoE)COMPLETEDPHASE32016-04-012019-11-122019-11-12
NCT02508168Phase 1 Bioavailability Study of SYR-322METCOMPLETEDPHASE12016-042016-042016-04
NCT02388971Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular DiseaseWITHDRAWNPHASE22016-042016-042016-04
NCT02655224A Placebo-Controlled, Phase 3 Study of Relugolix (TAK-385) 40 mg in the Treatment of Pain Symptoms Associated With Uterine FibroidsCOMPLETEDPHASE32016-03-262017-05-192017-05-16
NCT02699749A Study to Evaluate TAK-931 in Participants With Advanced Nonhematologic TumorsCOMPLETEDPHASE12016-03-242019-12-212019-12-21
NCT02679508Vonoprazan Study in Patients With Erosive Esophagitis to Evaluate Long-term SafetyCOMPLETEDPHASE42016-03-202022-03-052022-03-05
NCT02525861GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage StudyCOMPLETEDPHASE32016-03-082020-07-292020-07-29
NCT02655237A Phase 3 Study to Evaluate the Efficacy and Safety of Relugolix (TAK-385) 40 mg Compared With Leuprorelin in the Treatment of Uterine FibroidsCOMPLETEDPHASE32016-03-052017-09-252017-05-17
NCT02586805Efficacy and Safety Study of DX-2930 to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAECOMPLETEDPHASE32016-03-032017-04-132017-04-13
NCT02716194BAX 826 Dose-Escalation Safety StudyCOMPLETEDPHASE12016-03-032017-01-172017-01-17
NCT02651155Lubiprostone for the Treatment of Chronic Idiopathic ConstipationCOMPLETEDPHASE32016-03-022017-01-112017-01-11
NCT02706834Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy ParticipantsCOMPLETEDPHASE12016-03-012016-06-172016-06-17
NCT02713061A Phase 2 Study of a Subcutaneous Injection of TAK-850 in Healthy Adult ParticipantsWITHDRAWNPHASE22016-032016-042016-04
NCT02663687Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of Recombinant Human C1 Esterase Inhibitor in Healthy Adult SubjectsCOMPLETEDPHASE12016-02-192016-12-052016-12-05
NCT02661490Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly PopulationCOMPLETEDPHASE22016-02-012017-09-292016-10-28
NCT02616315Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric SurgeryWITHDRAWNPHASE42016-022017-122017-10
NCT02625259A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-117 (MLN1117) in Healthy ParticipantsCOMPLETEDPHASE12016-01-082016-07-222016-05-16
NCT02611817Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)COMPLETEDPHASE32016-01-042019-08-062019-05-06
NCT02627677A Study Comparing Ponatinib and Nilotinib in Participants With Chronic Myeloid LeukemiaTERMINATEDPHASE32015-12-312021-01-202020-10-29
NCT02605525Efficacy and Safety of SM101 in the Treatment of IgA NephropathyWITHDRAWNPHASE22015-12-312016-11-302016-11-30
NCT02611830Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative ColitisCOMPLETEDPHASE32015-12-182018-08-212018-05-30
NCT02549170A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)COMPLETEDPHASE32015-12-152022-02-232022-02-23
NCT02605837A Study in Adolescents and Adults With Eosinophilic Esophagitis (EoE) Measuring Histologic Response and Determine if Reduction in Dysphagia is AchievedCOMPLETEDPHASE32015-12-072019-02-152019-01-24
NCT02613221A Phase I/II Study for the Safety and Efficacy of Panitumumab in Combination With TAS-102 for Patients With Colorectal CancerCOMPLETEDPHASE1, PHASE22015-12-072018-03-302017-10-06
NCT02302092An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract InfectionsTERMINATEDPHASE32015-12-012016-12-152016-02-02
NCT02614586Evaluation of TAK-058 and Ondansetron on P50 Auditory Gating in Participants With Stable SchizophreniaTERMINATEDPHASE12015-122016-042016-04
NCT02584777A Phase II Non-Controlled, Open-Label, Efficacy, Safety, Pharmacokinetic, and Pharmacodynamic Study of Pacritinib in MyelofibrosisWITHDRAWNPHASE22015-11-302020-08-312017-09-30
NCT02585960BAX 855 PK-guided DosingCOMPLETEDPHASE32015-11-232018-08-052018-08-05
NCT02541669A Single- and Multiple-Dose Study of the Pharmacokinetics of TAK-491 in Healthy Chinese ParticipantsCOMPLETEDPHASE12015-11-202017-03-172017-03-17
NCT02604407Safety and Efficacy Study of SHP465 in Adults Aged 18-55 Years With Attention-deficit/ Hyperactivity Disorder (ADHD)COMPLETEDPHASE32015-11-192016-03-242016-03-24
NCT02528786Blood Sample Collection Study for Pharmacogenomic Characterization of Participants That Previously Received Namilumab in M1-1188-002-EM (PRIORA, [NCT01317797]) StudyCOMPLETEDPHASE12015-11-192016-04-052016-04-05
NCT02615691A Study of PEGylated Recombinant Factor VIII (BAX855) in Previously Untreated Young Children With Severe Hemophilia ACOMPLETEDPHASE32015-11-122024-10-292024-10-29
NCT02540356Phase 1/2a Two-Arm Dose-Escalation Study of BAX69 in Subjects With Malignant Ascites of Ovarian CancerTERMINATEDPHASE1, PHASE22015-11-022016-05-262016-05-26
NCT02584959Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1 Esterase Inhibitor for the Prevention of Angioedema Attacks in Adolescents and Adults With Hereditary AngioedemaCOMPLETEDPHASE32015-11-012017-07-242017-07-24
NCT02584569Phase 1 TAK-915 Single-Dose Positron Emission Tomography (PET) Occupancy StudyCOMPLETEDPHASE12015-112016-042016-04
NCT02455622Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of AgeCOMPLETEDPHASE42015-10-282025-07-292025-07-29
NCT02578030Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHDCOMPLETEDPHASE12015-10-242015-11-102015-11-10
NCT02551055MLN1117 in Combination With Docetaxel, Paclitaxel, and Other Investigational Anticancer Agents to Treat Participants With Gastric and Gastroesophageal AdenocarcinomaTERMINATEDPHASE12015-10-152017-02-172017-02-17
NCT02381288Effects of TAK-448 in Middle-aged and Older Men With Low TestosteroneTERMINATEDPHASE22015-09-102016-04-082016-04-08
NCT02539134TAK-935 Multiple Rising Dose Study in Healthy ParticipantsCOMPLETEDPHASE12015-092016-042016-04
NCT02555618Phase 2 Study of TAK-850 in Comparison With Influenza Hemagglutinin (HA) Vaccine in Healthy Adult ParticipantsCOMPLETEDPHASE22015-092015-122015-12
NCT01967251Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile DysfunctionWITHDRAWNPHASE22015-092016-092016-09
NCT02480764Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With HypertensionCOMPLETEDPHASE32015-08-272017-10-132017-09-22
NCT02466386Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity DisorderCOMPLETEDPHASE32015-08-212020-01-032020-01-03
NCT02512068A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal DiseaseCOMPLETEDPHASE32015-08-072018-04-242018-04-24
NCT02427958A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese ParticipantsCOMPLETEDPHASE42015-08-072018-11-232018-11-23
NCT02504320Phase 1, Febuxostat XR Relative Bioavailability StudyCOMPLETEDPHASE12015-082015-102015-09
NCT02451150A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With HypertensionCOMPLETEDPHASE32015-082015-092015-09
NCT02517866Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in AsiaCOMPLETEDPHASE42015-07-132016-11-252016-11-15
NCT02337751A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease ParticipantsCOMPLETEDPHASE32015-07-102017-03-142017-03-14
NCT02477020A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of SchizophreniaCOMPLETEDPHASE22015-07-012016-07-272016-07-13
NCT02497235A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935COMPLETEDPHASE12015-072016-012015-12
NCT02467270Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of DosesCOMPLETEDPHASE22015-06-302025-04-232020-04-14
NCT02497469An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative ColitisCOMPLETEDPHASE32015-06-292019-01-182018-09-26
NCT02153112Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in ChildrenCOMPLETEDPHASE22015-06-232018-06-202018-06-20
NCT02466425Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)COMPLETEDPHASE32015-06-182016-02-162016-02-16
NCT02448810Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal CancerTERMINATEDPHASE22015-06-152017-02-152017-02-15
NCT02425098Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in SingaporeCOMPLETEDPHASE22015-06-032017-09-182017-09-18
NCT02393209Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung CancerTERMINATEDPHASE1, PHASE22015-06-032017-01-202017-01-12
NCT02056015A Phase I Study of MLN6907 in Patients With Metastatic ColorectalCOMPLETEDPHASE12015-062015-092015-09
NCT02457247Calcichew D3 Preference Study in Participants Eligible for Calcium and Vitamin D Supplementation.COMPLETEDPHASE42015-062015-082015-08
NCT02480439A Study to Assess the Relative Bioavailability and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy ParticipantsCOMPLETEDPHASE12015-062015-092015-08
NCT02394795Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRCCOMPLETEDPHASE32015-05-292022-01-142022-01-14
NCT02448719Single-Dose Phase 1 Study of TAK-792COMPLETEDPHASE12015-05-272016-01-282016-01-28
NCT02410499Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With MacroalbuminuriaWITHDRAWNPHASE22015-05-202015-11-172015-11-17
NCT02461160Phase 1, TAK-915-1001, Single-Rising Dose, Multiple-Rising Dose, Drug-Drug Interaction, Relative Bioavailability, Food Effect, and Effect on Elderly Participants StudyCOMPLETEDPHASE12015-05-122016-08-012016-08-01
NCT02402166Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity DisorderCOMPLETEDPHASE22015-04-152016-06-302016-06-30
NCT02412787Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094COMPLETEDPHASE2, PHASE32015-04-142024-04-182024-04-18
NCT02389816A Phase 3 Study of Lu AA21004 in Patients With Major Depressive DisorderCOMPLETEDPHASE32015-04-102018-03-162018-03-16
NCT02312258A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT)COMPLETEDPHASE32015-04-092022-08-262019-08-12
NCT02350816An Extension Study to Determine Safety and Efficacy for Pediatric Patients With MPS Type IIIA Disease Who Participated in Study HGT-SAN-093.TERMINATEDPHASE22015-04-082019-04-122019-04-12
NCT02393378Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to MethotrexateTERMINATEDPHASE22015-04-082016-11-162016-06-27
NCT02283268Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing SurgeryCOMPLETEDPHASE32015-04-012016-07-062016-07-06
NCT02388737Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive EsophagitisCOMPLETEDPHASE32015-04-012018-12-312018-12-24
NCT02426021Phase 1 Single Subcutaneous Dose Study of MLN1202WITHDRAWNPHASE12015-042015-112015-11
NCT02430870TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE12015-042015-112015-09
NCT02425111Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's DiseaseCOMPLETEDPHASE32015-03-302018-02-212017-06-02
NCT02386839Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)COMPLETEDPHASE22015-03-262021-09-282021-09-28
NCT02412722A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic MalignanciesCOMPLETEDPHASE12015-03-262018-05-312018-05-31
NCT02388724Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive EsophagitisCOMPLETEDPHASE32015-03-242017-07-272017-07-27
NCT02367352Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid TumorsTERMINATEDPHASE12015-03-192017-05-232017-05-23
NCT02351960Dexlansoprazole in Asian Participants With Gastroesophageal Reflux DiseaseCOMPLETEDPHASE42015-03-192016-07-132016-06-22
NCT03888755A Study of Icatibant for Acute Attacks of Hereditary Angioedema in Japanese ParticipantsCOMPLETEDPHASE32015-03-182016-02-122016-02-12
NCT02413255Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single- and Multiple-Doses of TAK-020 in Healthy VolunteersCOMPLETEDPHASE12015-03-182017-05-042017-05-04
NCT02372097A Phase 1, Bioequivalence Study of SYR-472 25mg and 50mg TabletsCOMPLETEDPHASE12015-032015-042015-04
NCT02367872Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepatic ImpairmentCOMPLETEDPHASE12015-032016-062016-06
NCT02396147Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy ParticipantsCOMPLETEDPHASE12015-032015-062015-04
NCT02400775A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia.WITHDRAWNPHASE42015-032016-042016-04
NCT02401464A Bioequivalence Study of TAK-536 Pediatric FormulationCOMPLETEDPHASE12015-032015-052015-05
NCT02382640Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release CapsuleCOMPLETEDPHASE12015-032015-052015-05
NCT02475278Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle VaccineCOMPLETEDPHASE22015-02-262015-09-092015-04-07
NCT02284906AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer DiseaseTERMINATEDPHASE32015-02-122018-05-082018-01-31
NCT02371980Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)COMPLETEDPHASE42015-02-102019-04-252019-03-01
NCT02337725A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease PatientsCOMPLETEDPHASE32015-02-072016-09-152016-09-15
NCT02337764A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease ParticipantsCOMPLETEDPHASE32015-02-032016-09-292016-09-29
NCT02369796A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic HypogonadismTERMINATEDPHASE22015-022015-112015-10
NCT02389881Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy ParticipantsCOMPLETEDPHASE12015-022015-122015-12
NCT02370615Drug-Drug Interaction Study Between TAK-272 and Itraconazole, Digoxin or MidazolamCOMPLETEDPHASE12015-022015-042015-04
NCT02374164Food Effect Study of Febuxostat XR in Healthy ParticipantsCOMPLETEDPHASE12015-022015-042015-03
NCT02367885Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric ParticipantsCOMPLETEDPHASE1, PHASE22015-022015-052015-05
NCT02337738A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease ParticipantsCOMPLETEDPHASE2, PHASE32015-01-272016-09-172016-09-17
NCT02327169A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic MalignanciesCOMPLETEDPHASE12015-01-142018-07-022018-07-02
NCT02338713Effect of Calcium 500 mg and Vitamin D3 1000 IU Chewable Tablet on Intestinal Calcium AbsorptionCOMPLETEDPHASE12015-012015-022015-02
NCT02348658A Phase 1 Food Effect Study of TAK-536TCH Final Formulation TabletCOMPLETEDPHASE12015-012015-032015-03
NCT02324569A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 DiabetesCOMPLETEDPHASE32014-12-272016-12-282016-12-28
NCT02340819Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)COMPLETEDPHASE32014-12-182018-11-052018-11-05
NCT02379091Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA)COMPLETEDPHASE22014-12-172016-12-052016-05-11
NCT02093663Safety and Efficacy of MMX Mesalamine/Mesalazine in Pediatric Subjects With Mild to Moderate Ulcerative ColitisCOMPLETEDPHASE32014-12-122018-11-282018-11-28
NCT02302066Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy ParticipantsCOMPLETEDPHASE22014-12-052019-02-182019-02-18
NCT02391038MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Guanylyl Cyclase CTERMINATEDPHASE12014-122015-102015-10
NCT02313155Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy AdultsCOMPLETEDPHASE1, PHASE22014-122015-012015-01
NCT01927913Treatment of Iron Overload Requiring Chelation TherapyWITHDRAWNPHASE22014-11-202015-10-302015-10-30
NCT02277691A Phase III Long-term Study of TAK-536TCH in Participants With Essential HypertensionCOMPLETEDPHASE32014-11-072016-04-252016-04-25
NCT02284516A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)COMPLETEDPHASE32014-11-062015-10-052015-10-05
NCT02286518TAK-114 Single- and Multiple-Dose Phase 1 StudyCOMPLETEDPHASE12014-112015-042015-04
NCT02354599Single-Dose Study of MT203COMPLETEDPHASE12014-112015-052015-05
NCT02322606A Phase 1, Single and Multiple Dose Study of TAK-137WITHDRAWNPHASE12014-112015-052015-05
NCT02210091BAX 855 Pediatric StudyCOMPLETEDPHASE32014-10-312015-10-232015-10-23
NCT02259010A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory LymphomaCOMPLETEDPHASE12014-10-222016-10-212015-03-27
NCT02337946Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal CarcinomaCOMPLETEDPHASE22014-10-162017-08-312017-03-31
NCT02332824A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and MicroalbuminuriaCOMPLETEDPHASE22014-10-162016-08-182016-08-18
NCT02216084Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP)COMPLETEDPHASE12014-09-302016-02-222016-02-22
NCT02252354TAK-385 Phase I Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability StudyCOMPLETEDPHASE12014-092014-102014-10
NCT02214147Pharmacokinetics of Alisertib in Adults With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic FunctionCOMPLETEDPHASE12014-08-212016-07-182016-04-05
NCT02193087Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)COMPLETEDPHASE22014-08-062015-05-192015-05-19
NCT02202759A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal JunctionTERMINATEDPHASE22014-08-042016-01-152016-01-15
NCT02219256A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy ParticipantsCOMPLETEDPHASE12014-082016-042016-04
NCT02684396Phase 1, TAK-648, Single-Rising Dose StudyCOMPLETEDPHASE12014-082015-072015-04
NCT02204579A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium ConcentrationsCOMPLETEDPHASE22014-07-182015-05-042015-05-04
NCT02181413A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell TransplantCOMPLETEDPHASE32014-07-162023-09-082018-04-16
NCT02202785A Study of MLN0264 in Patients With Pancreatic CancerTERMINATEDPHASE22014-07-022016-01-152016-01-15
NCT02162758Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency AblationTERMINATEDPHASE22014-072016-042016-04
NCT02203916Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With HypertensionCOMPLETEDPHASE32014-072016-022016-01
NCT02209506Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese ParticipantsTERMINATEDPHASE12014-072014-122014-09
NCT02201056Safety, Tolerability, and Pharmacokinetics of Escalating Single Doses of TAK-935COMPLETEDPHASE12014-072015-072015-07
NCT02170220Pharmacokinetics, Safety and Tolerability of Vortioxetine in Normal Hepatic Function or Severe Hepatic ImpairmentCOMPLETEDPHASE12014-072014-122014-11
NCT02170402China ADVATE PTP StudyCOMPLETEDPHASE42014-06-262016-05-312016-05-31
NCT02176486Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis (LN)TERMINATEDPHASE12014-06-092018-01-192017-03-30
NCT02094573A Study to Evaluate the Efficacy of Brigatinib (AP26113) in Participants With Anaplastic Lymphoma Kinase (ALK)-Positive, Non-small Cell Lung Cancer (NSCLC) Previously Treated With CrizotinibCOMPLETEDPHASE22014-06-042020-02-272016-02-29
NCT02125292Taste Assessment Study of SHP429 in Healthy Adult SubjectsCOMPLETEDPHASE12014-06-022014-06-192014-06-19
NCT02276274Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male SubjectsCOMPLETEDPHASE32014-062014-062014-06
NCT02079805A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-RCOMPLETEDPHASE42014-062016-042016-04
NCT02135445Safety and Efficacy of TAK-385 for Patients With Localized Prostate CancerCOMPLETEDPHASE22014-062015-122015-12
NCT02129777Efficacy and Safety of Namilumab (MT203) for Plaque PsoriasisCOMPLETEDPHASE22014-062016-022015-09
NCT02163421Bioavailability and Pharmacokinetics of Vedolizumab in Healthy Participants Following Single Subcutaneous AdministrationCOMPLETEDPHASE12014-062015-012014-12
NCT02163915Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder.TERMINATEDPHASE12014-062014-112014-11
NCT02153099Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of ENV8058 (TAK-058) in Healthy ParticipantsCOMPLETEDPHASE12014-062014-112014-11
NCT02142504Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy AdultsCOMPLETEDPHASE22014-05-152016-01-062016-01-06
NCT02093923A Double-Blind, Multiple Ascending Dose Study to Assess Safety, Tolerability and Pharmacokinetics of DX-2930 in Hereditary Angioedema ParticipantsCOMPLETEDPHASE12014-05-142015-05-182015-05-18
NCT02038647Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)COMPLETEDPHASE22014-05-122017-07-102016-01-03
NCT02049814Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 DiabetesCOMPLETEDPHASE42014-05-092016-06-282016-06-01
NCT02141659A Study of TAK-385 in Hormone Treatment-naïve Participants With Prostate CancerCOMPLETEDPHASE12014-05-012017-04-202017-04-20
NCT02128490Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal ImpairmentCOMPLETEDPHASE22014-052015-102015-09
NCT02122770Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid TumorsCOMPLETEDPHASE12014-04-012017-06-052017-06-05
NCT02139046Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With GoutCOMPLETEDPHASE32014-042015-112015-11
NCT02913508Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's DiseaseWITHDRAWNPHASE22014-042015-122015-12
NCT02038907Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP VaccineCOMPLETEDPHASE22014-03-282015-06-192015-06-19
NCT02083185A Phase 2 Study to Evaluate the Safety and Efficacy of TAK-385, Together With a Leuprorelin Observational Cohort, in Participants With Prostate CancerCOMPLETEDPHASE22014-03-262017-02-232016-01-01
NCT02055118Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive ImpairmentCOMPLETEDPHASE2, PHASE32014-03-242017-09-282017-09-28
NCT02052141Safety and Efficacy Study of CINRYZE for Prevention of Angioedema Attacks in Children Ages 6-11 With Hereditary AngioedemaCOMPLETEDPHASE32014-03-202017-05-042017-05-04
NCT01953783Mass Balance, Pharmacokinetics and Metabolism Study of IXAZOMIBCOMPLETEDPHASE12014-03-192016-02-092014-12-17
NCT01990534A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin LymphomaCOMPLETEDPHASE42014-03-142020-03-122016-03-24
NCT02046070Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple MyelomaCOMPLETEDPHASE22014-03-052018-06-292018-06-29
NCT02079844Roflumilast Plus Antipsychotics Proof of Mechanism Study in SchizophreniaCOMPLETEDPHASE12014-032015-062015-06
NCT02074345Phase III Study of Intramuscular TAK-816 in Healthy InfantsCOMPLETEDPHASE32014-032015-032015-03
NCT02111252A Phase 1/2 Study of a Intramuscular Injection of TAK-850 in Healthy Adult SubjectsCOMPLETEDPHASE1, PHASE22014-032014-042014-04
NCT02065401Pharmacokinetics of Granule and Tablet Formulations of Deferitazole (Disodium Salt) and a Capsule Formulation of Deferitazole (Magnesium Hydroxide Salt)WITHDRAWNPHASE12014-02-282014-03-192014-03-19
NCT02060526Randomized, Controlled, Open-label, Multicenter, Safety and Efficacy Study of rhHNS Administration Via an IDDD in Pediatric Patients With Early Stage MPS IIIA DiseaseCOMPLETEDPHASE22014-02-262016-06-012016-06-01
NCT02045264Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese VolunteersCOMPLETEDPHASE12014-02-212014-02-272014-02-27
NCT02039505Phase III Study of MLN0002 (300 mg) in the Treatment of Ulcerative ColitisCOMPLETEDPHASE32014-02-042018-06-282018-02-27
NCT02068443Comparative Study to Evaluate Efficacy and Safety When Metformin Hydrochloride 500 mg Once Daily is Added on to SYR-322 25 mg in Type 2 Diabetic Patients With Inadequate Glycemic Control Despite Treatment With SYR-322 25 mg in Addition to Diet and Exercise TherapyCOMPLETEDPHASE32014-022015-022015-02
NCT02063854A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 TabletsCOMPLETEDPHASE2, PHASE32014-022015-112015-11
NCT02064907Bioavailability, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets in Healthy ParticipantsCOMPLETEDPHASE12014-022014-042014-03
NCT02096458Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating TabletsCOMPLETEDPHASE12014-022014-022014-02
NCT02113020A Phase I Clinical Pharmacology Study of TAK-233 in Healthy SubjectsCOMPLETEDPHASE12014-022014-092014-09
NCT02045095A Dose Escalation Study of MLN7243 (TAK-243) in Adult Participants With Advanced Solid TumorsTERMINATEDPHASE12014-01-312016-11-092016-11-09
NCT02038920Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's DiseaseCOMPLETEDPHASE32014-01-282019-05-212019-01-25
NCT02009163Evaluate the Maintenance of Efficacy of SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating DisorderCOMPLETEDPHASE32014-01-272015-04-082015-04-08
NCT01909934Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Systemic Anaplastic Large Cell LymphomaCOMPLETEDPHASE42014-01-232024-08-292021-05-04
NCT01953081A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding IntoleranceCOMPLETEDPHASE1, PHASE22014-012014-102014-09
NCT02037477Phase 3 Study to Evaluate the Acid-Inhibitory Effect of Multiple Oral Doses of Vonoprazan (TAK-438)COMPLETEDPHASE32014-012014-032014-03
NCT01913405Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical ProceduresCOMPLETEDPHASE32013-12-202016-09-232016-09-23
NCT01972724Efficacy of Pioglitazone in Participants With Inadequately Controlled Type 2 Diabetes Mellitus Treated With Stable Triple Oral TherapyCOMPLETEDPHASE42013-12-162016-10-172016-10-17
NCT01987908Evaluation of Different Dose Regimens of Aes-103 Given for 28 Days to Subjects With Stable Sickle Cell DiseaseTERMINATEDPHASE22013-12-032015-03-162015-03-16
NCT01919801Blinded Safety & Efficacy Placebo Controlled Study of Icatibant for Angiotensin Converting Enzyme Inhibitor Induced AngioedemaCOMPLETEDPHASE32013-12-022015-08-222015-08-22
NCT02015780Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on HemodialysisWITHDRAWNPHASE32013-122016-012016-01
NCT01989169Pharmacokinetic Interaction Between SSP-004184 (SPD602) and Midazolam in Healthy Adult SubjectsCOMPLETEDPHASE12013-11-262014-01-062014-01-06
NCT01979185Effect of SSP-004184 (SPD602) on the Pharmacokinetics of Simvastatin in Healthy Adult SubjectsCOMPLETEDPHASE12013-11-182013-12-132013-12-13
NCT01952080A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel SyndromeCOMPLETEDPHASE32013-11-142015-01-092015-01-09
NCT01939899Phase 2 Study of Oral IXAZOMIB in Adult Participants With Relapsed and/or Refractory Follicular LymphomaCOMPLETEDPHASE22013-10-312017-03-232016-06-01
NCT01945593BAX 855 ContinuationCOMPLETEDPHASE32013-10-152018-03-022018-03-02
NCT01982253Fasiglifam 25 mg BID vs 50 mg QDTERMINATEDPHASE22013-102014-012014-01
NCT02370602An [^11C]T-773 Positron Emission Tomography (PET) Study to Determine Phosphodiesterase10A Occupancy by TAK-063COMPLETEDPHASE12013-102014-032014-02
NCT01830816Pharmacokinetics Study of Oral Ixazomib (MLN9708) in Relapsed/Refractory Multiple Myeloma and Advanced Solid Tumors Participants With Normal Renal Function or Severe Renal ImpairmentCOMPLETEDPHASE12013-09-162016-11-182015-03-03
NCT01890122Efficacy and Safety of Alogliptin and Metformin Fixed-Dose Combination in Participants With Type 2 DiabetesCOMPLETEDPHASE32013-092015-102015-09
NCT02447458MLN3126 Single Rising Dose StudyTERMINATEDPHASE12013-092014-022014-01
NCT01905553The Effect of Food on the Bioavailability of a Single Dose of SSP-004184SS in Healthy Adult SubjectsCOMPLETEDPHASE12013-08-272013-09-242013-09-24
NCT01898884Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's AtaxiaCOMPLETEDPHASE12013-08-132015-06-182015-06-18
NCT01923207A Single Increasing Dose Study to Assess Safety and Tolerability of DX-2930 in Healthy SubjectsCOMPLETEDPHASE12013-08-122014-01-072014-01-07
NCT01905540A Relative Bioavailability Study of SSP-004184AQ (Magnesium Salt) and SSP-004184SS (Disodium Salt)COMPLETEDPHASE12013-08-052013-09-202013-09-20
NCT01931566Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its OnsetTERMINATEDPHASE32013-08-012018-09-062018-07-24
NCT01892189Effects of TAK-063 on Preventing Ketamine-Induced Brain Activity Changes as Well as Psychotic-Like Symptoms in Healthy Male AdultsCOMPLETEDPHASE12013-082014-082014-08
NCT01898078Food Effect Study of Alisertib (MLN8237) in Participants With Advanced Solid Tumors or LymphomasCOMPLETEDPHASE12013-07-162017-01-242014-03-05
NCT01890785Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult VolunteersCOMPLETEDPHASE12013-07-152013-08-222013-08-22
NCT01916304Study of Dose Adjustment From Levothyroxine to a New Levothyroxine Sodium Test FormulationCOMPLETEDPHASE22013-072014-062014-06
NCT01900522Safety and Tolerability of Multiple Doses of ITI-214 in Healthy Adults and in Adults With Stable SchizophreniaTERMINATEDPHASE12013-072014-122014-09
NCT01967264Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican AdultsCOMPLETEDPHASE12013-072013-082013-08
NCT01899053A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic MalignanciesCOMPLETEDPHASE12013-06-282018-04-302017-01-31
NCT01844583Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of AlisertibCOMPLETEDPHASE12013-06-252016-09-062014-08-04
NCT01862328Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid TumorsCOMPLETEDPHASE12013-06-102018-05-212018-05-21
NCT01874665A Phase 2 Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal TumorCOMPLETEDPHASE22013-06-052016-07-312015-02-28
NCT02085252A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate CancerCOMPLETEDPHASE32013-06-032016-11-082016-11-08
NCT01879722Safety, Tolerability and Pharmacokinetic Study of Multiple Rising Doses of TAK- 063 in Participants With Stable Schizophrenia and Healthy ParticipantsCOMPLETEDPHASE12013-062014-062014-06
NCT01834274Comparison of Fasiglifam (TAK-875) With Sitagliptin When Used in Combination With Metformin in Patients With Type 2 DiabetesTERMINATEDPHASE32013-062014-032014-03
NCT02334982Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-137 in Healthy ParticipantsCOMPLETEDPHASE12013-062014-012014-01
NCT01887938An Efficacy and Safety Study of HGT-1110 in Participants With Metachromatic LeukodystrophyACTIVE_NOT_RECRUITINGPHASE1, PHASE22013-05-232025-09-302025-09-30
NCT01461954FST-100 in the Treatment of Acute Viral ConjunctivitisCOMPLETEDPHASE22013-05-172014-03-102014-03-10
NCT01824446AME (Absorption, Metabolism, and Excretion) of Radiolabeled SSP-004184COMPLETEDPHASE12013-05-012013-05-292013-05-29
NCT01848210Efficacy and Safety of Coumarin and Troxerutin in the Symptomatic Treatment of Chronic Venous InsufficiencyCOMPLETEDPHASE42013-052015-092015-09
NCT01829464TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 DiabetesTERMINATEDPHASE32013-052014-032014-02
NCT01763996The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Participants With Chronic Stable AnginaCOMPLETEDPHASE42013-052015-042015-03
NCT01850524IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple MyelomaCOMPLETEDPHASE32013-04-292022-06-242019-12-02
NCT01814826Study of MLN4924 Plus Azacitidine in Treatment-naive Participants With Acute Myelogenous Leukemia (AML) Who Are 60 Years or OlderCOMPLETEDPHASE12013-04-102018-04-082016-05-03
NCT01751360SYR-472 Open-label StudyCOMPLETEDPHASE32013-04-012013-08-012013-08-01
NCT01829477Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 DiabetesTERMINATEDPHASE32013-042014-022014-02
NCT01806584An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Placement of an Arteriovenous Graft to Facilitate Hemodialysis AccessTERMINATEDPHASE22013-03-282014-10-232014-10-23
NCT01806545An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Creation of an Arteriovenous Fistula to Facilitate Hemodialysis AccessCOMPLETEDPHASE22013-03-262014-10-272014-10-27
NCT01771809Long-Term Safety Of PF-00547659 In Ulcerative ColitisCOMPLETEDPHASE22013-03-182017-12-132017-12-13
NCT01807000Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled Prucalopride Succinate in VolunteersCOMPLETEDPHASE12013-03-182013-04-282013-04-28
NCT01842841Multicenter Extension Study of Velaglucerase Alfa in Japanese Patients With Gaucher DiseaseCOMPLETEDPHASE32013-03-132014-10-082014-10-08
NCT01786876Adsorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled SPD557 in VolunteersCOMPLETEDPHASE12013-03-072013-04-122013-04-12
NCT02072330Study to Evaluate the Efficacy and Safety of Combined Administration of TAK-536CCB and Hydrochlorothiazide in Patients With Grade I or II Essential Hypertension.COMPLETEDPHASE2, PHASE32013-032013-122013-12
NCT01707667Study to Investigate Prucalopride vs. Polyethylene Glycol 3350 on Colon ActivityCOMPLETEDPHASE42013-02-272013-11-272013-11-27
NCT01757405Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand RegimenCOMPLETEDPHASE32013-02-202014-11-112014-11-11
NCT01696279A Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Investigate and Compare the Efficacy, Safety and Tolerability of Lanthanum Carbonate With Calcium Carbonate in Hyperphosphataemic Children and Adolescents With Chronic Kidney Disease on DialysisCOMPLETEDPHASE22013-02-152018-11-162018-11-16
NCT01765426Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet InjectorCOMPLETEDPHASE12013-02-152014-06-262014-06-26
NCT01687608Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia BACTIVE_NOT_RECRUITINGPHASE1, PHASE22013-02-112030-01-172030-01-17
NCT01756157Subcutaneous CINRYZE With Recombinant Human Hyaluronidase for Prevention of Angioedema AttacksCOMPLETEDPHASE22013-02-042013-09-132013-09-13
NCT01760993Long-term Safety of SPD489 When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of SchizophreniaTERMINATEDPHASE32013-02-012013-04-012013-04-01
NCT01760889SPD489 Low Dose and High Dose Ranges When Added to Stable Doses of Antipsychotic Medications in Clinically Stable Adults With Negative Symptoms of SchizophreniaTERMINATEDPHASE32013-02-012013-04-012013-04-01
NCT01736475Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study)COMPLETEDPHASE2, PHASE32013-01-312014-07-172014-07-17
NCT01218438Phase 2/3 Study of IGSC, 20% in PIDDCOMPLETEDPHASE2, PHASE32013-01-282015-03-132015-03-13
NCT01714947Mass Balance, Pharmacokinetics and Metabolism Study of AlisertibCOMPLETEDPHASE12013-01-242013-06-142013-04-04
NCT01728792Impact of SC vs IM Administration of DENVax (TDV) on Safety and ImmunogenicityCOMPLETEDPHASE12013-01-222013-11-212013-11-01
NCT01659658Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) AmyloidosisTERMINATEDPHASE32012-12-262022-07-112022-07-11
NCT01470664FST-100 in the Treatment of Acute Adenoviral ConjunctivitisCOMPLETEDPHASE22012-12-172014-05-232014-05-23
NCT01645930Phase 1 Pharmacokinetic Study of Oral Ixazomib Plus Lenalidomide and Dexamethasone in Adult Asian Participants With Relapsed and/or Refractory Multiple MyelomaCOMPLETEDPHASE12012-12-172017-04-112014-07-14
NCT01743729A Phase 3 Study to Evaluate the Efficacy of Lifitegrast in Subjects With Dry EyeCOMPLETEDPHASE32012-12-072013-10-012013-10-01
NCT01736579Long-Term Study of IGIV, 10% in Alzheimer´s DiseaseTERMINATEDPHASE32012-11-292013-06-042013-06-04
NCT01718509SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating DisorderCOMPLETEDPHASE32012-11-262013-09-202013-09-20
NCT01718483SPD489 in Adults Aged 18-55 Years With Moderate to Severe Binge Eating DisorderCOMPLETEDPHASE32012-11-262013-09-252013-09-25
NCT01712490A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin LymphomaACTIVE_NOT_RECRUITINGPHASE32012-11-092026-01-202017-04-20
NCT01732263Study of SSP-004184 (SPD602) in Healthy Adults and Subjects With Impaired Liver FunctionCOMPLETEDPHASE12012-11-092013-04-012013-04-01
NCT01620255A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative ColitisCOMPLETEDPHASE22012-11-022016-02-042014-09-22
NCT01738698Adjunctive SPD489 to Antipsychotic Medication in Clinically Stable Adults With Persistent Predominant Negative Symptoms of SchizophreniaTERMINATEDPHASE32012-11-012013-04-012013-04-01
NCT01732692Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel PreparationCOMPLETEDPHASE32012-112013-042013-04
NCT01716455Study of SSP-004184 (FBS0701) in Healthy Adults and Elderly Subjects and in Subjects With Impaired Renal FunctionCOMPLETEDPHASE12012-10-292013-03-102013-03-10
NCT01636206Safety Study of Lifitegrast to Treat Dry EyeCOMPLETEDPHASE32012-10-162014-03-032014-03-03
NCT01647542Study to Evaluate the Efficacy and Safety of Daily Oral TAK-875 25 and 50mg in Asia Pacific Adults With Type 2 DiabetesTERMINATEDPHASE32012-102014-032014-02
NCT01604941Pharmacokinetics of SSP-004184 in the Treatment of Chronic Iron Overload Requiring Chelation TherapyTERMINATEDPHASE22012-09-142014-04-182014-04-18
NCT01685216Efficacy and Safety Study of Velaglucerase Alfa in Children and Adolescents With Type 3 Gaucher DiseaseCOMPLETEDPHASE1, PHASE22012-09-142015-03-152015-03-15
NCT01686711A Double-blind, Parallel Group, Comparative Study of Coadministration AD-4833 and SYR-322COMPLETEDPHASE42012-092013-122013-12
NCT01685151A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 DisorderWITHDRAWNPHASE32012-092015-112015-11
NCT01667133A Study of Ponatinib in Japanese Participants With Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL)COMPLETEDPHASE1, PHASE22012-08-312018-08-022018-08-02
NCT01657019Open Label Extension in Adults With Binge Eating Disorder (BED)COMPLETEDPHASE32012-08-212014-10-212014-10-21
NCT01666314Study in Japan and Ex-Japan to Characterize the Pharmacokinetic and Pharmacodynamic Response to Orteronel (TAK-700) in Chemotherapy-Naive Participants With Castration-Resistant Prostate CancerCOMPLETEDPHASE1, PHASE22012-08-202016-09-012013-09-12
NCT01671111Study for Transfusionally Iron Overloaded Children, Adolescents and Adults Using FBS0701 (SSP-004184)TERMINATEDPHASE22012-08-142014-04-242014-04-24
NCT01564537A Phase 3 Study Comparing Oral Ixazomib Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Participants With Relapsed and/or Refractory Multiple MyelomaCOMPLETEDPHASE32012-08-012022-02-082014-10-01
NCT01677182Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 DisorderTERMINATEDPHASE32012-082014-092014-08
NCT01651351GLASSIA Infusion Rate StudyCOMPLETEDPHASE42012-07-312013-01-162013-01-16
NCT01642212OBS in Adolescent and Adults With EOE: A Phase II, Randomized, Double-Blind, Placebo Controlled, Study With an Open Label ExtensionCOMPLETEDPHASE22012-07-232014-10-302014-10-30
NCT01611974Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant RecipientsCOMPLETEDPHASE22012-07-172014-12-052014-12-05
NCT01609257Norovirus Bivalent-Vaccine Efficacy StudyCOMPLETEDPHASE1, PHASE22012-07-162014-03-182014-03-01
NCT01541579Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's DiseaseCOMPLETEDPHASE32012-072016-112015-07
NCT02629848Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung CancerTERMINATEDPHASE32012-072015-032014-09
NCT01642615Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in AdolescentsCOMPLETEDPHASE22012-072014-112014-11
NCT01642602Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in AdolescentsCOMPLETEDPHASE22012-072014-012014-01
NCT01630746A Randomized, Double-Blind, Multicenter Study to Evaluate the Acid-inhibitory and Dose-response Efficacy of TAK-438 (20 mg, 40 mg) in Patients With Proton Pump Inhibitor (PPI) - Resistant Erosive EsophagitisCOMPLETEDPHASE32012-072013-092013-09
NCT01549977Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable AnginaTERMINATEDPHASE22012-072012-112012-11
NCT01639222Human Pharmacology Trial of Calcium-vitamin D3 Tablet in Healthy ParticipantsCOMPLETEDPHASE12012-072012-082012-08
NCT01765790Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid TumorsCOMPLETEDPHASE12012-06-142016-07-282016-07-28
NCT01578499A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study)COMPLETEDPHASE32012-06-112018-07-062016-05-31
NCT01482962Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell LymphomaCOMPLETEDPHASE32012-06-112017-12-182015-06-30
NCT04272775A Study of MLN9708 in Japanese Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)TERMINATEDPHASE12012-06-052019-02-152019-02-15
NCT01253382Study to Evaluate Ecallantide in Paediatric Patients With Acute Attacks of Hereditary AngioedemaWITHDRAWNPHASE2, PHASE32012-06-012015-04-01
NCT01577758Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase CCOMPLETEDPHASE12012-062014-022014-02
NCT01582854Efficacy and Safety of Actovegin in Post-stroke Cognitive Impairment (PSCI)COMPLETEDPHASE32012-062014-112014-11
NCT01609582Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseTERMINATEDPHASE32012-062014-052014-05
NCT01515865Clinical Efficacy of Midodrine in Symptomatic Orthostatic HypotensionCOMPLETEDPHASE42012-05-232013-11-112013-11-11
NCT01560403A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021COMPLETEDPHASE32012-05-212013-07-232013-07-23
NCT01518946Tilt-Table Study of the Clinical Efficacy of Midodrine in Symptomatic Orthostatic HypotensionCOMPLETEDPHASE42012-05-142013-06-222013-06-22
NCT01597401A Single Dose Study of the Safety, Blood Levels and Biological Effects of Aes-103 Compared to Placebo in Subjects With Stable Sickle Cell DiseaseCOMPLETEDPHASE12012-05-122013-06-072013-06-07
NCT01387594Evaluate PF-00547659 On Cerebrospinal Fluid Lymphocytes In Volunteers With Crohn's Disease Or Ulcerative Colitis Who Failed Or Did Not Tolerate Anti-TNFsCOMPLETEDPHASE12012-05-032015-11-262014-03-31
NCT01632007Double-blind Comparative Study of SYR-472COMPLETEDPHASE32012-05-012013-07-012013-07-01
NCT01568398A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Low-Dose Aspirin TherapyCOMPLETEDPHASE32012-052013-082013-08
NCT01585792Double Blind Comparative Study of TAK-875COMPLETEDPHASE32012-052012-122012-12
NCT01601132Drug Interaction Study of Colchicine and TheophyllineCOMPLETEDPHASE42012-052012-072012-07
NCT01552915Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity DisorderCOMPLETEDPHASE42012-04-172014-01-222014-01-22
NCT01492088Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin LymphomaCOMPLETEDPHASE1, PHASE22012-04-162018-04-122016-10-12
NCT01552902Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity DisorderCOMPLETEDPHASE42012-04-032014-05-222014-05-22
NCT01549964Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 DiabetesTERMINATEDPHASE32012-042014-032014-03
NCT01546649A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast CancerCOMPLETEDPHASE32012-042014-122014-12
NCT01564862Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive DisorderCOMPLETEDPHASE22012-042014-022014-02
NCT01568385A Unblinded Study of TAK-438 (20 mg) for Prevention of Recurrence of Gastric or Duodenal Ulcer During Long-Term Non-Steroid Anti-Inflammatory Drug (NSAID) TherapyCOMPLETEDPHASE32012-042013-092013-09
NCT01552928Effect of Anagrelide Hydrochloride on Any Changes in Heart Function in Healthy VolunteersCOMPLETEDPHASE12012-03-292012-07-252012-07-25
NCT01500694Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in EuropeCOMPLETEDPHASE32012-03-202015-09-152015-09-15
NCT01614574Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher DiseaseCOMPLETEDPHASE32012-03-022013-05-252013-05-25
NCT01500135Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular SurgeryCOMPLETEDPHASE32012-032015-122015-06
NCT01546623A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal TherapyCOMPLETEDPHASE32012-032014-042014-04
NCT01456247Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose AspirinCOMPLETEDPHASE32012-032013-102013-10
NCT01452685A Long-term Extension Study of TAK-385 in the Treatment of EndometriosisCOMPLETEDPHASE22012-032013-122013-12
NCT01436175SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension StudyTERMINATEDPHASE32012-02-272014-03-272014-03-27
NCT01472939Selective 5-HT4 Receptor Agonist and Proton Pump Inhibitor (PPI) in Subjects With Gastroesophageal Reflux Disease (GERD)COMPLETEDPHASE22012-02-272013-05-142013-05-14
NCT01512758A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or LymphomasCOMPLETEDPHASE12012-02-062013-10-082013-10-08
NCT01510028Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD)COMPLETEDPHASE1, PHASE22012-02-022017-01-202017-01-20
NCT01542632A Comparison of the Safety and Immunogenicity of Various Schedules of Dengue Vaccine in Healthy Adult VolunteersCOMPLETEDPHASE12012-02-012014-01-102014-01-01
NCT01496469Effect of Febuxostat on Blood PressureCOMPLETEDPHASE22012-022014-082014-08
NCT01521962Study of Combination Therapy With SYR-322COMPLETEDPHASE32012-022013-032013-03
NCT01386658A Pharmacokinetic, Tolerability and Safety Study of Icatibant in Children and Adolescents With Hereditary AngioedemaCOMPLETEDPHASE32012-01-272018-03-122018-03-12
NCT01234298SPD489 as Adjunctive Treatment in Adults With Negative Symptoms of SchizophreniaWITHDRAWNPHASE32012-01-272014-02-242014-02-24
NCT01524887Phase 3 IGIV, 10% in Alzheimer´s DiseaseTERMINATEDPHASE32012-01-232013-07-162013-07-16
NCT01470469SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)COMPLETEDPHASE22012-01-042013-07-152013-07-15
NCT01743222Intralymphatic eASC Administration in Healthy VolunteersCOMPLETEDPHASE12012-012012-062012-05
NCT01481116Efficacy and Safety of TAK-875 Compared to Glimepiride When Used With Metformin in Participants With Type 2 DiabetesTERMINATEDPHASE32012-012014-042014-03
NCT01496430Efficacy and Safety of Azilsartan Medoxomil Used in Combination With Metformin in Participants With Hypertension and DiabetesTERMINATEDPHASE32012-012013-052013-05
NCT01505127Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. PyloriCOMPLETEDPHASE32012-012013-062013-06
NCT01433419Open-label Study of TAK-875COMPLETEDPHASE32012-012012-122012-12
NCT01496443TAK-875 Glimepiride Drug-Interaction StudyCOMPLETEDPHASE12012-012012-052012-05
NCT01485796Tolerability and Safety of IGI, 10% With rHuPH20 in PIDDCOMPLETEDPHASE2, PHASE32011-12-292013-01-012013-01-01
NCT01488994BAX 326 Pediatric StudyCOMPLETEDPHASE2, PHASE32011-12-202013-05-142013-05-14
NCT01507896BAX 326 Surgery Study in Hemophilia B PatientsCOMPLETEDPHASE32011-12-192014-05-152014-05-15
NCT01467713Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I DisorderTERMINATEDPHASE32011-122015-032015-03
NCT01467700Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I DisorderTERMINATEDPHASE32011-122015-032015-03
NCT01474369Efficacy of TAK-438 Compared to Placebo in the Treatment of Non-Erosive Gastroesophageal Reflux DiseaseCOMPLETEDPHASE32011-122013-022013-02
NCT01541670Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus NephritisTERMINATEDPHASE12011-11-282012-12-312012-12-31
NCT01304277This Study is Designed to Evaluate PD/PK and Safety of Replagal Manufactured by Two Different Processes.COMPLETEDPHASE22011-11-172012-12-282012-12-28
NCT01511250Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 YearsCOMPLETEDPHASE22011-11-162016-04-152016-04-01
NCT01454076Pharmacokinetics Study of Oral IXAZOMIB in Participants With Advanced Nonhematologic Malignancies or LymphomaCOMPLETEDPHASE12011-11-102016-06-162015-04-01
NCT01469637Sulfamethoxazole Drug Interaction Study With MMX® Mesalazine/MesalamineCOMPLETEDPHASE12011-11-072011-12-202011-12-20
NCT01410227Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD)COMPLETEDPHASE32011-11-012014-02-012014-02-01
NCT01456195Comparison of TAK-875 (Fasiglifam) With Placebo in Participants With Type 2 DiabetesCOMPLETEDPHASE32011-112013-072013-07
NCT01456130Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 DiabetesCOMPLETEDPHASE32011-112013-032013-03
NCT01452711Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Gastric UlcerCOMPLETEDPHASE32011-112012-122012-12
NCT01497288A Trial to Investigate the Pharmacokinetics (PK) of Single Doses of 200 µg, 400 µg and 2 x 400 µg of Intranasal Fentanyl Spray (INFS) in Healthy SubjectsCOMPLETEDPHASE12011-112011-122011-12
NCT01456117Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly ParticipantsCOMPLETEDPHASE12011-112012-072012-07
NCT01383928Study of Oral IXAZOMIB in Combination With Lenalidomide and Dexamethasone in Participants With Newly Diagnosed Multiple MyelomaCOMPLETEDPHASE1, PHASE22011-10-312017-11-272014-10-13
NCT01460147Osteoporosis and MRI Study in HemophiliaTERMINATEDNA2011-10-302012-04-132012-04-13
NCT01436149Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderCOMPLETEDPHASE32011-10-272013-12-232013-12-23
NCT01457339Assess the Safety and Pharmacokinetics of Ascending, Multiple Oral Doses of SPD489 in Adults With SchizophreniaCOMPLETEDPHASE12011-10-212012-01-202012-01-20
NCT01436162Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderCOMPLETEDPHASE32011-10-192013-12-102013-12-10
NCT01442688Amoxicillin Drug Interaction Study With MMX® Mesalazine/MesalamineCOMPLETEDPHASE12011-10-072011-11-202011-11-20
NCT01434511Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia ATERMINATEDPHASE32011-10-032013-07-292013-07-29
NCT01449370Dose Escalation Study of TAK-117 (MLN1117) in Subjects With Advanced CancerCOMPLETEDPHASE12011-102016-012015-07
NCT01478971Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on DialysisCOMPLETEDPHASE32011-102013-022013-02
NCT01456169A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil AloneCOMPLETEDPHASE32011-102013-012012-12
NCT01452750Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)COMPLETEDPHASE32011-102013-062013-06
NCT01458301Efficacy and Safety of TAK-385 in the Treatment of EndometriosisCOMPLETEDPHASE22011-102013-082013-08
NCT01433406Long-term Study of TAK-875COMPLETEDPHASE32011-102013-122013-12
NCT01452763Efficacy and Safety of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Low-dose AspirinCOMPLETEDPHASE32011-102013-042013-04
NCT01452724Efficacy and Safety of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Duodenal UlcerCOMPLETEDPHASE32011-102013-022013-02
NCT01459367Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Maintenance Treatment of Healed Erosive EsophagitisCOMPLETEDPHASE32011-102013-032013-03
NCT01452659Efficacy and Safety of TAK-385 in the Treatment of Uterine FibroidsCOMPLETEDPHASE22011-102012-092012-09
NCT01599819BAX 855 Dose-Escalation Safety StudyCOMPLETEDPHASE12011-09-302012-07-272012-07-27
NCT01449461A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-Tumor Activity of the Oral Anaplastic Lymphoma Kinase (ALK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Brigatinib (AP26113)COMPLETEDPHASE1, PHASE22011-09-202020-02-182015-11-16
NCT01081132Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HClCOMPLETEDPHASE32011-09-192013-05-162013-05-16
NCT01425008Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic MelanomaCOMPLETEDPHASE12011-09-152018-10-162017-04-11
NCT01426763A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human HyaluronidaseCOMPLETEDPHASE22011-09-122011-11-282011-11-28
NCT01431807Long-term Study of SYR-472COMPLETEDPHASE32011-09-012013-06-012013-06-01
NCT01456260Long-term Extension Study of TAK-438 for the Prevention of Recurrent Gastric or Duodenal Ulcers During Therapy of Non-steroidal Anti-inflammatory Drug (NSAID)COMPLETEDPHASE32011-092013-12
NCT01452776Long-Term Safety Study of TAK-438 in the Maintenance Treatment of Healed Erosive EsophagitisCOMPLETEDPHASE32011-092013-072013-07
NCT01421498Safety and Efficacy Study of SAR 1118 to Treat Dry Eye Conducted in a Controlled Adverse Environment (CAE) (OPUS-1)COMPLETEDPHASE32011-08-292012-04-282012-04-28
NCT01376700Early Prophylaxis Immunologic Challenge (EPIC) StudyTERMINATEDPHASE32011-08-262012-11-162012-11-16
NCT01147302A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated RejectionCOMPLETEDPHASE22011-08-242013-06-282013-04-19
NCT01418365Metronidazole Drug Interaction Study With MMX® Mesalazine/MesalamineCOMPLETEDPHASE12011-08-222011-10-052011-10-05
NCT01455181A Study to Investigate the Safety and Tolerability of NPSP558, for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study in HungaryCOMPLETEDPHASE32011-08-192012-04-262012-04-26
NCT01415349SSP-002358 Drug Interaction Study With OmeprazoleCOMPLETEDPHASE12011-08-112011-09-282011-09-28
NCT01363908Safety, Efficacy and Pharmacokinetics of an Oral Iron Chelator Given for a Year to Pediatric Patients With Iron OverloadTERMINATEDPHASE22011-08-102014-05-132014-05-13
NCT01298141A Multicenter Open-Label Treatment Protocol to Observe the Safety of Replagal (Agalsidase Alfa) Enzyme Replacement Therapy in Canadian Patients With Fabry DiseaseCOMPLETEDPHASE32011-08-102017-09-252017-09-25
NCT01397825MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab +/- VincristineCOMPLETEDPHASE1, PHASE22011-08-092016-10-052015-02-05
NCT01390545VELVET, a Dose Range Finding Trial of Veltuzumab in Subjects With Moderate to Severe Rheumatoid ArthritisTERMINATEDPHASE22011-082012-102012-10
NCT01414920Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE22011-082012-082012-08
NCT01376479Safety and Immunogenicity Study of an Inactivated Vaccine Against Hand, Foot and Mouth Disease Caused by Enterovirus 71COMPLETEDPHASE12011-082012-042011-11
NCT01429051A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough PainCOMPLETEDPHASE32011-082013-012013-01
NCT01132638Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux DiseaseCOMPLETEDPHASE32011-082012-062012-06
NCT01402947Ciprofloxacin XR Drug Interaction Study With MMX® Mesalazine/MesalamineCOMPLETEDPHASE12011-07-252011-08-302011-08-30
NCT01328756Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE42011-07-072014-09-302014-09-30
NCT01298492A Study To Monitor Long-Term Treatment With PF-00547659COMPLETEDPHASE22011-07-012016-07-272016-07-27
NCT01395147Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive DisorderCOMPLETEDPHASE32011-072013-052013-05
NCT01391663Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean ParticipantsCOMPLETEDPHASE12011-072011-092011-09
NCT01259726Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile InfectionCOMPLETEDPHASE22011-06-272013-06-112013-06-11
NCT01335685Study of Oral Ixazomib in Combination With Melphalan and Prednisone in Participants With Newly Diagnosed Multiple MyelomaCOMPLETEDPHASE1, PHASE22011-06-272016-12-292016-12-29
NCT01412385Immune Globulin Subcutaenous (Human), 20%COMPLETEDPHASE2, PHASE32011-06-202014-05-132014-05-13
NCT01343823Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced AngioedemaTERMINATEDPHASE22011-06-012012-06-012012-06-01
NCT01364649Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual DysfunctionCOMPLETEDPHASE32011-062013-122013-12
NCT01379846Study of TAK-816 in Healthy InfantsCOMPLETEDPHASE32011-062013-022013-02
NCT01435759SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive DisorderCOMPLETEDPHASE22011-05-312014-01-172014-01-17
NCT01363492Safety Study of Replagal® Therapy in Children With Fabry DiseaseCOMPLETEDPHASE22011-05-122013-04-172013-04-17
NCT01291173Forced-dose Titration of SPD489 in Adults With Binge Eating DisorderCOMPLETEDPHASE22011-05-102012-01-302012-01-30
NCT01355081Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderCOMPLETEDPHASE32011-052012-122012-12
NCT01330381Prucalopride in Pediatric Subjects With Functional ConstipationCOMPLETEDPHASE32011-04-282013-03-012013-03-01
NCT01318902Study of Oral Ixazomib in Adult Participants With Relapsed or Refractory Light Chain AmyloidosisCOMPLETEDPHASE12011-04-272018-11-132018-11-13
NCT01286779BAX 326 (rFIX) Continuation StudyCOMPLETEDPHASE32011-04-122017-06-292017-06-29
NCT01424228Evaluation of Long-term Prucalopride Treatment With Chronic Constipation in Subjects Aged ≥ 18 YearsCOMPLETEDPHASE42011-04-062012-12-192012-12-19
NCT01297309A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE)COMPLETEDPHASE32011-04-062018-06-082018-06-08
NCT01276509Study To Test Whether PF-00547659 Is Safe And Improves Disease Symptoms In Patients With Crohn's DiseaseCOMPLETEDPHASE22011-04-062015-10-092014-02-07
NCT01355627TASALL - TachoSil® Against Liquor LeakCOMPLETEDPHASE32011-042013-062013-06
NCT01274221Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)WITHDRAWNPHASE32011-03-062011-05-042011-05-04
NCT01299727Extension of Study HGT-SAN-055 Evaluating Administration of rhHNS in Patients With Sanfilippo Syndrome Type A (MPS IIIA)TERMINATEDPHASE1, PHASE22011-03-012019-04-122019-04-12
NCT01504347Phase 1/2 Lyme Vaccine StudyCOMPLETEDPHASE1, PHASE22011-03-012014-02-282011-09-13
NCT01663116Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis PatientsCOMPLETEDPHASE1, PHASE22011-032013-012013-01
NCT01317797A Trial to Evaluate the Safety and Tolerability of Namilumab (MT203) in Patients With Mild to Moderate Rheumatoid ArthritisCOMPLETEDPHASE12011-032013-082013-08
NCT01299805Effects of Vortioxetine (Lu AA21004) on the Concentrations of Selected Neurotransmitters in Healthy Male AdultsCOMPLETEDPHASE12011-032011-072011-06
NCT01309828Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Hypertension and Kidney DiseaseCOMPLETEDPHASE32011-032012-102012-10
NCT01311076TAK-329 Glucose Clamp StudyCOMPLETEDPHASE12011-032012-012011-12
NCT01351350Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid MalignanciesCOMPLETEDPHASE12011-02-282017-09-152017-09-15
NCT01268098Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)COMPLETEDPHASE32011-02-092011-11-112011-09-23
NCT01244490Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE32011-01-172013-05-012013-05-01
NCT01128179Effects of Lanthanum Carbonate on FGF-23 in Subjects With Stage 3 CKDCOMPLETEDPHASE22010-12-062012-04-162012-04-16
NCT01370863An Explorative Trial to Evaluate the Pharmacodynamic Effect of SPD557 on Reflux Parameters in Refractory GERD PatientsTERMINATEDPHASE22010-12-022012-05-292012-05-29
NCT01289119Efficacy and Safety of Alogliptin in Participants With Type 2 DiabetesCOMPLETEDPHASE32010-122011-122011-12
NCT01217957A Study of Ixazomib Administered in Combination With Lenalidomide and Low-Dose Dexamethasone in Patients With Newly Diagnosed Multiple MyelomaCOMPLETEDPHASE1, PHASE22010-11-222018-02-022013-03-08
NCT01193257Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.COMPLETEDPHASE32010-11-152016-02-292013-05-16
NCT01178294Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia ACOMPLETEDPHASE2, PHASE32010-11-102013-10-092013-07-01
NCT01216293Effect of Dexlansoprazole on Bone HomeostasisCOMPLETEDPHASE12010-11-012015-02-012014-08-01
NCT01255787Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderCOMPLETEDPHASE2, PHASE32010-112012-042012-03
NCT01224756Efficacy of Tinoridine in Treating Pain and Inflammation in AdultsCOMPLETEDPHASE42010-112011-102011-10
NCT01235338Co-Administration of LDX (SPD489) and Venlafaxine XR (EFFEXOR XR) in Healthy VolunteersCOMPLETEDPHASE12010-10-282011-01-172010-12-30
NCT01467661Long-term Safety of SPD422 in Japanese Adults With Essential ThrombocythaemiaCOMPLETEDPHASE32010-10-272015-05-012015-05-01
NCT01214915Effect of SPD422 on Platelet Lowering and Safety in Japanese Adults With At Risk Essential ThrombocythaemiaCOMPLETEDPHASE32010-10-272012-10-242012-10-24
NCT01224639Safety and Immunogenicity Study to Assess TDV, a Live Attenuated Tetravalent Vaccine for Prevention of Dengue FeverCOMPLETEDPHASE12010-10-112011-11-092011-06-09
NCT01130844Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative ColitisCOMPLETEDPHASE12010-10-082013-06-272013-06-27
NCT01193244Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate CancerCOMPLETEDPHASE32010-10-012016-04-072014-01-01
NCT01207440Ponatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)COMPLETEDPHASE22010-09-302019-01-172018-12-20
NCT01209351Effect of Teduglutide on Gastric Emptying in Healthy SubjectsCOMPLETEDPHASE12010-09-282010-11-082010-11-08
NCT01147926Evaluation of Prucalopride in Male Subjects With Chronic Constipation.COMPLETEDPHASE32010-09-232013-10-252013-10-25
NCT01191372First-in-Human and Proof-of-Mechanism Study of ARC19499 Administered to Hemophilia PatientsTERMINATEDPHASE12010-09-152011-12-282011-12-28
NCT01168401Bivalent Norovirus Vaccine StudyCOMPLETEDPHASE12010-09-032013-01-092013-01-01
NCT01152996Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension StudyCOMPLETEDPHASE32010-092013-052013-05
NCT01183234SPD544 High Strength Bioequivalence StudyCOMPLETEDPHASE12010-08-272010-10-222010-10-22
NCT01094288A Phase 1 Study of Alisertib Participants With Advanced Solid Tumors Including Castration-Resistant Prostate Cancer Receiving a Standard Docetaxel RegimenCOMPLETEDPHASE12010-08-172017-01-042014-02-28
NCT01186419Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron OverloadCOMPLETEDPHASE22010-08-132013-01-082013-01-08
NCT01506141An Extension Study of HGT-HIT-045 Evaluating Long-Term Safety and Clinical Outcomes of Idursulfase-IT in Conjunction With Elaprase in Pediatric Participants With Hunter Syndrome and Cognitive ImpairmentCOMPLETEDPHASE1, PHASE22010-08-012024-04-302024-04-30
NCT02774902TAK-438_110 Drug Interaction With Cytochrome P450 3A4 (CYP3A4) Inhibitor ClarithromycinCOMPLETEDPHASE12010-082010-092010-09
NCT01192022TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection SurgeryCOMPLETEDPHASE32010-082013-052013-05
NCT01179516Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCOMPLETEDPHASE32010-082012-062012-05
NCT01174446Pivotal Study (Pharmacokinetics, Efficacy, Safety) of BAX 326 (rFIX) in Hemophilia B PatientsCOMPLETEDPHASE32010-07-292012-05-032012-05-03
NCT01175213Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PIDCOMPLETEDPHASE32010-07-282013-08-062013-08-06
NCT01159210Efficacy and Safety of Prothromplex Total (Prothrombin Complex Concentrate) in Oral Anticoagulant ReversalCOMPLETEDPHASE42010-07-092012-04-072012-04-07
NCT01084655Study of TAK-700 in Combination With Docetaxel and Prednisone in Men With Metastatic Castration-Resistant Prostate CancerCOMPLETEDPHASE1, PHASE22010-072016-032013-01
NCT01163266Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCOMPLETEDPHASE32010-072012-012012-01
NCT01124149Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative ColitisCOMPLETEDPHASE42010-06-292012-12-072012-12-07
NCT01106430Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to MethylphenidateCOMPLETEDPHASE32010-06-282012-07-192012-07-19
NCT01096784IGF-1/IGFBP3 Prevention of Retinopathy of PrematurityCOMPLETEDPHASE22010-06-182016-03-302016-03-30
NCT01095497A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE AdministrationCOMPLETEDPHASE22010-06-072010-12-162010-12-16
NCT01095510CINRYZE for the Treatment of Hereditary Angioedema Attacks in Children Under the Age of 12COMPLETEDPHASE22010-06-022012-04-172012-04-17
NCT01155778Safety, Tolerability, Ascending Dose and Dose Frequency Study of rhHNS Via an IDDD in MPS IIIA PatientsCOMPLETEDPHASE1, PHASE22010-06-012012-09-012012-09-01
NCT01153009Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCOMPLETEDPHASE32010-062012-032012-03
NCT01128881IMMUNINE Pre-Treatment StudyCOMPLETEDPHASE42010-05-312012-08-282012-08-28
NCT01117051Prucalopride Effects on Subjects With Chronic Non-cancer Pain Suffering From Opioid Induced ConstipationTERMINATEDPHASE32010-05-192012-08-132012-08-13
NCT01101022Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE42010-05-192010-11-292010-11-29
NCT01081145Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE32010-05-112013-06-032013-06-03
NCT01078376A Comparative Single-Dose Pharmacokinetic (PK) and Safety Study of Azilsartan Medoxomil in Children With Hypertension and in Healthy AdultsTERMINATEDPHASE12010-052013-092013-07
NCT01084278Healthy and Renal Impairment Study of Colcrys (Colchicine, USP)COMPLETEDPHASE42010-052011-022011-02
NCT01099215Study of PVS-10200 for the Treatment of Restenosis in Patients With Peripheral Artery Disease (TRIUMPH)COMPLETEDPHASE1, PHASE22010-04-302012-10-312012-06-30
NCT01101035Cardiovascular Safety of Febuxostat and Allopurinol in Participants With Gout and Cardiovascular Comorbidities (CARES)COMPLETEDPHASE32010-04-232017-07-182017-05-15
NCT01091428Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast CancerCOMPLETEDPHASE22010-04-162017-07-192014-08-12
NCT01124643Extension Study of TKT028 Evaluating Safety and Clinical Outcomes of Replagal® in Adult Patients With Fabry DiseaseCOMPLETEDPHASE32010-04-132013-07-082013-07-08
NCT01096680Pharmacodynamic Profile of SPD489 in Healthy Adult Males Undergoing a Nocturnal Period of Acute Sleep LossCOMPLETEDPHASE22010-04-052010-07-182010-07-18
NCT01082640Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal ImpairmentCOMPLETEDPHASE22010-042012-052012-05
NCT02287402Postmarketing Clinical Study on AO-128COMPLETEDPHASE42010-032012-112012-11
NCT01078389Effect of Febuxostat on Joint Damage in Hyperuricemic Subjects With Early GoutCOMPLETEDPHASE22010-032013-092013-09
NCT01045096Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux DiseaseCOMPLETEDPHASE12010-032011-022011-02
NCT01077284Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate StonesCOMPLETEDPHASE22010-022011-112011-11
NCT01063101Phase 1 Dosing Study of BAX 513 in Healthy VolunteersCOMPLETEDPHASE12010-01-292010-08-012010-07-22
NCT01010750Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)COMPLETEDPHASE12010-01-052010-03-282010-03-28
NCT01058707Dose Escalation Study of MLN0128 in Participants With Advanced MalignanciesCOMPLETEDPHASE12010-01-042019-02-072019-02-07
NCT01033071Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension.COMPLETEDPHASE32010-012010-112010-10
NCT01007097Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE22009-122010-092010-09
NCT00942175A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.COMPLETEDPHASE12009-122010-072010-06
NCT00920647A Safety and Dose Ranging Study of Idursulfase (Intrathecal) Administration Via an Intrathecal Drug Delivery Device in Pediatric Patients With Hunter Syndrome Who Have Central Nervous System Involvement and Are Receiving Treatment With Elaprase®COMPLETEDPHASE1, PHASE22009-11-182012-10-292012-10-29
NCT00997984Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)COMPLETEDPHASE32009-11-172010-10-092010-10-09
NCT01350999Long-term Efficacy and Safety Study of TAK-085 in Participants With HypertriglyceridemiaCOMPLETEDPHASE32009-112011-012011-01
NCT01350973Efficacy of TAK-085 in Participants With HypertriglyceridemiaCOMPLETEDPHASE32009-112010-122010-12
NCT01023581Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 DiabetesCOMPLETEDPHASE32009-112011-062011-06
NCT00914862Pharmacokinetic and Safety of Ramelteon Between Adolescents With Insomnia and Healthy AdultsCOMPLETEDPHASE12009-112011-042011-03
NCT00985725SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive DisorderCOMPLETEDPHASE22009-10-292011-04-182011-04-18
NCT00932698Study of Oral Ixazomib in Adult Participants With Relapsed and/or Refractory (RR) Multiple MyelomaCOMPLETEDPHASE12009-10-122017-05-232013-06-20
NCT00963820Study Evaluating the Safety and Tolerability of Weekly Dosing of Oral IXAZOMIB in Adult Patients With Relapsed and Refractory Multiple MyelomaCOMPLETEDPHASE12009-102014-012012-09
NCT00931918Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma PatientsCOMPLETEDPHASE22009-102015-082015-08
NCT00996281Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential HypertensionCOMPLETEDPHASE32009-102011-112011-11
NCT01012479Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe HypertensionCOMPLETEDPHASE42009-102010-062010-05
NCT00997204EASSI - Evaluation of the Safety of Self-Administration With IcatibantCOMPLETEDPHASE32009-09-252011-06-222011-06-22
NCT00962091Study of MLN8237 in Participants With Advanced Solid TumorsCOMPLETEDPHASE12009-09-252014-07-012011-12-28
NCT00930644Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)COMPLETEDPHASE32009-09-212013-01-242013-01-24
NCT00922272Efficacy, Safety, and Tolerability of SPD489 in Adults With Schizophrenia and Predominant Negative SymptomsCOMPLETEDPHASE22009-09-142011-01-202011-01-20
NCT00957268Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes MellitusCOMPLETEDPHASE12009-092013-112013-11
NCT00968708Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary SyndromeCOMPLETEDPHASE32009-092013-062013-04
NCT00914966A Study to Evaluate the Safety and Effect of Escalating Doses of CINRYZECOMPLETEDPHASE42009-08-312012-05-242012-05-24
NCT00961675FST-201 in the Treatment of Acute Otitis ExternaCOMPLETEDPHASE32009-08-312010-06-302010-06-30
NCT00973284Norwalk Vaccine StudyCOMPLETEDPHASE1, PHASE22009-08-042010-08-182010-04-07
NCT00926185A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)COMPLETEDPHASE22009-08-032010-02-182010-02-18
NCT00945646FST-201 In The Treatment of Acute Fungal Otitis ExternaTERMINATEDPHASE32009-07-312010-07-312010-07-31
NCT00945802FST-201 In The Treatment of Acute Otitis ExternaTERMINATEDPHASE32009-07-312010-07-312010-07-31
NCT00905424Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an AntidepressantCOMPLETEDPHASE22009-07-302010-08-042010-08-04
NCT00912093A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)COMPLETEDPHASE32009-07-162010-10-012010-10-01
NCT00941486FST-100 Ophthalmic Suspension in Acute Adenoviral ConjunctivitisTERMINATEDPHASE22009-06-302010-06-302010-06-30
NCT00916032Pharmacokinetic Study of ADVATE 3000 IU in Previously Treated Patients With Severe Hemophilia ACOMPLETEDPHASE42009-06-292010-04-012010-04-01
NCT00919867A Drug Interaction Study of SPD503 and Vyvanse Administered Alone and In Combination in Normal Healthy VolunteersCOMPLETEDPHASE12009-06-242009-07-302009-07-30
NCT00925704The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy VolunteersCOMPLETEDPHASE12009-06-012009-07-312009-07-31
NCT01372969Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.COMPLETEDPHASE1, PHASE22009-062010-092010-09
NCT02525536A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid TumorsCOMPLETEDPHASE12009-062014-052014-05
NCT00790933An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's DiseaseCOMPLETEDPHASE32009-05-222017-10-312017-10-31
NCT00901576A Drug Interaction Study of SPD503 and Concerta Administered Alone and In Combination in Normal Healthy VolunteersCOMPLETEDPHASE12009-05-182009-07-062009-07-06
NCT00847210Pharmacokinetic and Safety of Dexlansoprazole in Adolescents With Gastroesophageal Reflux DiseaseCOMPLETEDPHASE12009-052009-092009-09
NCT00877487Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity DisorderCOMPLETEDPHASE42009-04-302010-07-082010-07-08
NCT00882687Efficacy Study to Evaluate the Effectiveness of 3 Concentrations of SAR 1118 in Allergic ConjunctivitisCOMPLETEDPHASE22009-04-242009-05-102009-05-10
NCT00875017Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult VolunteersCOMPLETEDPHASE12009-04-202009-06-162009-06-16
NCT00851721Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer InhibitorCOMPLETEDPHASE32009-03-312012-10-172012-10-17
NCT00853307MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal CarcinomaCOMPLETEDPHASE22009-03-232011-01-272009-11-23
NCT00830869A Phase 1 Study of IXAZOMIB in Adult Patients With Advanced Nonhematologic MalignanciesCOMPLETEDPHASE12009-03-022012-04-202012-04-20
NCT00856284Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE32009-032012-102012-10
NCT00846365Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe HypertensionCOMPLETEDPHASE32009-032010-062010-06
NCT00770835Efficacy and Safety of Pioglitazone in Treating Subjects With Vascular Complications Associated With Type 2 Diabetes Mellitus.COMPLETEDPHASE42009-032011-052011-05
NCT00830518A Phase 2 Trial of MLN8237 in Adult Participants With Acute Myelogenous Leukemia and High-Grade Myelodysplastic SyndromeCOMPLETEDPHASE22009-02-102011-07-042010-02-02
NCT00807495Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's LymphomaCOMPLETEDPHASE22009-02-102013-02-132011-01-04
NCT00847808Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor TherapyCOMPLETEDPHASE32009-022010-042010-04
NCT00818883Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe HypertensionCOMPLETEDPHASE32009-022009-112009-11
NCT00880750Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy AdultsCOMPLETEDPHASE12009-01-282009-06-222009-06-22
NCT00784654Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17COMPLETEDPHASE32009-01-272011-10-262011-10-26
NCT00762073Dose-Ranging Study of Oral Viscous Budesonide in Pediatrics With Eosinophilic EsophagitisCOMPLETEDPHASE22009-01-082010-04-022010-04-02
NCT01318135Long-term Safety Study of Alogliptin Used in Combination With Sulfonylurea or Metformin in Participants With Type 2 Diabetes in JapanCOMPLETEDPHASE2, PHASE32009-012010-042010-01
NCT00847626Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe HypertensionCOMPLETEDPHASE32009-012010-072010-05
NCT00949091Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 DiabetesCOMPLETEDPHASE12009-012009-072009-07
NCT00864851Safety and Efficacy Study of Several Replagal Dosing Regimens on Cardiac Function in Adults With Fabry DiseaseCOMPLETEDPHASE32008-12-292012-07-052012-06-01
NCT00818662A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s DiseaseCOMPLETEDPHASE32008-12-192012-12-102012-12-10
NCT00732615Use of NPSP558 in the Treatment of HypoparathyroidismCOMPLETEDPHASE32008-12-182011-09-282011-09-28
NCT00814320Gammagard Liquid and rHuPH20 in PIDCOMPLETEDPHASE32008-12-182010-11-112010-11-11
NCT00816660Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand DiseaseCOMPLETEDPHASE12008-12-012010-08-312010-08-31
NCT01378390Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's DiseaseTERMINATEDPHASE32008-122010-022010-02
NCT00798967Study of Teduglutide Effectiveness in Parenteral Nutrition (PN)-Dependent Short Bowel Syndrome (SBS) SubjectsCOMPLETEDPHASE32008-11-252011-01-252011-01-25
NCT00776555Compare Subjective Drug Liking & Pharmacokinetics of Vyvanse™ and ADDERALL XR® When Administered as an Oral SolutionTERMINATEDPHASE12008-11-212009-03-312009-03-31
NCT00763971Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17COMPLETEDPHASE32008-11-172011-03-162011-03-16
NCT00764868Vyvanse Adolescent Open-Label Safety and Efficacy Extension StudyCOMPLETEDPHASE32008-11-132010-04-222010-04-22
NCT00806962Phase 1 Norwalk Vaccine StudyCOMPLETEDPHASE12008-112009-102009-10
NCT00735371Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE32008-10-082009-04-062009-04-06
NCT02141711TAK-438 - Safety, Blood Levels & Effects of Repeated DosesCOMPLETEDPHASE12008-102009-022009-02
NCT02123953Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-438 in Healthy Male ParticipantsCOMPLETEDPHASE12008-102009-032009-03
NCT00752791Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.COMPLETEDPHASE22008-102010-052010-05
NCT00746733Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTCCOMPLETEDPHASE12008-09-082008-10-262008-10-26
NCT00734578Efficacy and Safety of SPD503 in Combination With PsychostimulantsCOMPLETEDPHASE32008-09-022009-12-102009-12-10
NCT00744627Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults.COMPLETEDPHASE32008-092009-072009-07
NCT00752609Safety and Efficacy of Peginesatide Injection for the Maintenance of Anemia in Chronic Renal Failure Participants Who Are on Hemodialysis or Do Not Require Dialysis and Previously Treated With Darbepoetin Alfa.COMPLETEDPHASE22008-092009-122009-12
NCT00666263Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor NeuropathyCOMPLETEDPHASE32008-08-222011-08-112011-08-11
NCT00952822Pharmacokinetic Study of ADVATE Reconstituted in 2 mL Sterile Water for InjectionCOMPLETEDPHASE12008-08-082009-10-232009-10-23
NCT00735709Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCOMPLETEDPHASE32008-082009-082009-07
NCT01318083Efficacy and Safety of Alogliptin Used in Combination With Sulfonylurea in Participants With Type 2 Diabetes in JapanCOMPLETEDPHASE2, PHASE32008-082009-042009-04
NCT01318109Efficacy and Safety of Alogliptin Used Combination With Metformin in Participants With Type 2 Diabetes in JapanCOMPLETEDPHASE2, PHASE32008-082009-042009-04
NCT00770640Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.COMPLETEDPHASE22008-082010-062010-06
NCT00697515Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)COMPLETEDPHASE32008-07-182008-12-202008-12-20
NCT00697346Study of MLN8237 in Participants With Advanced Hematological MalignanciesCOMPLETEDPHASE12008-07-112016-10-192016-10-01
NCT00722917Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes MellitusTERMINATEDPHASE22008-072009-042009-04
NCT00660920Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological MalignanciesCOMPLETEDPHASE12008-062016-052016-05
NCT00734071An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderCOMPLETEDPHASE32008-062009-032009-01
NCT00707980Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderCOMPLETEDPHASE32008-062010-082010-07
NCT00730691Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderCOMPLETEDPHASE32008-062009-022009-02
NCT00731120Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderCOMPLETEDPHASE32008-062009-022009-01
NCT00707993Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly DiabeticsCOMPLETEDPHASE32008-062010-082010-08
NCT00722137Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell LymphomaCOMPLETEDPHASE32008-05-012017-06-172014-01-01
NCT01318122Long-term Safety Study of Alogliptin Used in Combination With Thiazolidine in Participants With Type 2 Diabetes in JapanCOMPLETEDPHASE2, PHASE32008-052009-082009-08
NCT00708175Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.COMPLETEDPHASE42008-052011-022011-01
NCT00770445Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.COMPLETEDPHASE42008-052010-072010-07
NCT00672984Guanfacine Immediate-release Electrocardiogram Results (QTc) StudyCOMPLETEDPHASE12008-04-182008-08-072008-08-07
NCT00672620Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive DisorderCOMPLETEDPHASE32008-042008-122008-11
NCT00672958Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive DisorderCOMPLETEDPHASE32008-042008-112008-11
NCT00696436An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.COMPLETEDPHASE32008-042009-082009-08
NCT00666406Pharmacokinetic Comparison of Advate rAHF-PFM With Recombinate rAHF in Patients With Severe Hemophilia ACOMPLETEDPHASE42008-03-312009-02-182009-02-18
NCT00635427An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher DiseaseCOMPLETEDPHASE32008-03-132012-12-282012-12-28
NCT00677053Safety and Efficacy of TAK-442 in Subjects With Acute Coronary SyndromesCOMPLETEDPHASE22008-032010-062010-06
NCT00627016A Study of Dexlansoprazole Modified Release Formulation to Treat Night HeartburnCOMPLETEDPHASE32008-032009-032009-03
NCT00681811Open-Label Extension Study of Recombinant Human Arylsulfatase A (HGT-1111) in Late Infantile MLDTERMINATEDPHASE22008-02-202010-10-222010-10-22
NCT00633477Efficacy and Safety of Resatorvid in Patients With Sepsis-induced Cardiovascular and Respiratory FailureTERMINATEDPHASE32008-022009-022009-02
NCT00553631Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher DiseaseCOMPLETEDPHASE32008-01-292009-05-052009-05-05
NCT00760214Efficacy and Safety Study of Azilsartan Medoxomil Compared to Ramipril for Treating Essential HypertensionCOMPLETEDPHASE32008-012009-042009-04
NCT00629876A Safety and Tolerability Study of Peginesatide in Anemic Cancer Patients Receiving Cytotoxic Chemotherapy.TERMINATEDPHASE12008-012008-062008-06
NCT00775840Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.COMPLETEDPHASE32008-012008-122008-12
NCT00607386Safety and Clinical Outcomes in Hunter Syndrome Patients 5 Years of Age and Younger Receiving Idursulfase TherapyCOMPLETEDPHASE42007-12-312011-07-082011-07-08
NCT00545103Prevention of Recurrence of DiverticulitisCOMPLETEDPHASE32007-12-062011-11-282011-11-28
NCT00333528A Study of Plasma-Derived Human Butyrylcholinesterase Administered IntramuscularlyCOMPLETEDPHASE12007-12-012008-08-012008-04-01
NCT00591578Efficacy and Safety Comparison of Azilsartan Medoxomil to Valsartan in Participants With Essential HypertensionCOMPLETEDPHASE32007-122010-032009-09
NCT00545740Prevention of Recurrence of DiverticulitisCOMPLETEDPHASE32007-11-282012-03-052012-03-05
NCT01318070Efficacy and Safety of Alogliptin Used Combination With Thiazolidine in Participants With Type 2 Diabetes in JapanCOMPLETEDPHASE2, PHASE32007-112008-102008-10
NCT00651664A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Participants With Advanced MalignanciesCOMPLETEDPHASE12007-10-222011-04-052010-09-01
NCT00546871Comparison of Intravenous and Subcutaneous Administration of IGIV, 10% in Primary Immunodeficiency (PID) SubjectsCOMPLETEDPHASE2, PHASE32007-10-032009-09-012009-07-01
NCT00641732Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee ReplacementCOMPLETEDPHASE22007-102008-102008-10
NCT02141698Safety, Tolerability, and Pharmacokinetics of TAK-438 in Healthy Western Male Subjects, Preliminary Food Effect Analysis, and an Ethnic Comparison With Japanese SubjectsCOMPLETEDPHASE12007-102008-022008-02
NCT00532558Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With HypercholesterolemiaTERMINATEDPHASE32007-102008-052008-05
NCT00593736Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase SyndromeCOMPLETEDPHASE22007-102008-052008-05
NCT00591266Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential HypertensionCOMPLETEDPHASE32007-102009-042009-03
NCT00591253Efficacy and Safety of Azilsartan Medoxomil in African American Participants With Essential HypertensionCOMPLETEDPHASE32007-102009-042009-04
NCT02123927Safety, Tolerability and Pharmacokinetics of TAK-438 in Healthy Male ParticipantsCOMPLETEDPHASE12007-092007-122007-12
NCT00591773Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential HypertensionCOMPLETEDPHASE32007-092009-032009-03
NCT00915343Once-daily Oral Modified Release Hydrocortisone in Patients With Adrenal InsufficiencyCOMPLETEDPHASE2, PHASE32007-08-212009-01-282008-07-28
NCT00760968Efficacy and Safety of TAK-783 in Subjects With Rheumatoid ArthritisCOMPLETEDPHASE22007-082009-022009-02
NCT00756002Safety and Efficacy Study of Ramelteon in Subjects With Chronic InsomniaCOMPLETEDPHASE32007-082008-032008-03
NCT00819468Pharmacokinetics (PK) of 20 mg Teduglutide in Participants With Moderately Impaired Hepatic Function Compared to Healthy ParticipantsCOMPLETEDPHASE12007-07-262007-08-232007-08-23
NCT00478647Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With ImigluceraseCOMPLETEDPHASE2, PHASE32007-07-252009-06-262009-06-26
NCT00497796Maribavir Versus Oral Ganciclovir For The Prevention of Cytomegalovirus (CMV) Disease in Liver Transplant RecipientsCOMPLETEDPHASE32007-07-232009-09-142009-09-14
NCT00532311Efficacy of Lapaquistat Acetate Co-Administered With Statins in Subjects With HypercholesterolemiaTERMINATEDPHASE32007-072008-042008-04
NCT00655863Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.COMPLETEDPHASE32007-072009-122009-12
NCT00865228Efficacy of Lapaquistat Acetate in Subjects With HypercholesterolemiaTERMINATEDPHASE22007-072007-112007-11
NCT01289132Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential HypertensionCOMPLETEDPHASE22007-072008-072008-07
NCT00500071Dose-Optimization Study Evaluating the Efficacy, Safety and Tolerability of Vyvanse (Lisdexamfetamine Dimesylate) in Children Aged 6-12 Diagnosed With ADHDCOMPLETEDPHASE42007-06-282008-01-022008-01-02
NCT00500149A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE32007-06-132007-12-052007-12-05
NCT00514813Dynepo Long-Term Safety StudyTERMINATEDPHASE42007-06-062008-07-312008-07-31
NCT01263509Long-term Safety Study of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in JapanCOMPLETEDPHASE2, PHASE32007-062008-102008-10
NCT00696384A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionCOMPLETEDPHASE32007-062009-042009-04
NCT00727857Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.COMPLETEDPHASE32007-062008-082008-08
NCT00696241Efficacy and Safety of Azilsartan Medoxomil in Participants With Essential HypertensionCOMPLETEDPHASE32007-062008-102008-10
NCT00695955One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionCOMPLETEDPHASE32007-062010-052010-05
NCT00452478Conversion From Standard Phosphate Binder Therapy to Fosrenol® (Lanthanum Carbonate) in Chronic Kidney Disease Stage 5TERMINATEDPHASE42007-05-222007-12-102007-12-10
NCT00500903A Study of MLN8237, a Novel Aurora A Kinase Inhibitor, in Participants With Advanced Solid TumorsCOMPLETEDPHASE12007-05-152011-02-232010-08-01
NCT00446849Strategies in Maintenance for Patients Receiving Long-term Therapy (S.I.M.P.L.E.) With MMX (Multi-Matrix System) Mesalamine for Ulcerative Colitis (UC)COMPLETEDPHASE42007-05-012009-08-172009-08-17
NCT00653185Efficacy of SYR-472 in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE22007-052008-032008-03
NCT01263496Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in JapanCOMPLETEDPHASE22007-052008-092008-09
NCT00762359A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal UlcersTERMINATEDPHASE32007-052008-112008-11
NCT00471094Safety and Efficacy of Ilaprazole 5, 20 and 40 mg QD and Lansoprazole 30 mg QD on Healing of Erosive EsophagitisCOMPLETEDPHASE22007-052007-102007-10
NCT00458445A Study of SPD465 in Young Adult Drivers With Attention-Deficit Hyperactivity Disorder (ADHD) Using Driving SimulatorsWITHDRAWNPHASE32007-04-302007-06-152007-06-15
NCT00456508Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE)COMPLETEDPHASE32007-04-012010-09-012010-06-01
NCT00457015Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)COMPLETEDPHASE32007-04-012008-06-012008-06-01
NCT00506883MPC-004 for the Treatment of an Acute Gout FlareCOMPLETEDPHASE32007-042007-102007-10
NCT00787254Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory DrugsCOMPLETEDPHASE32007-042009-052009-05
NCT00770653Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.COMPLETEDPHASE32007-042009-052009-05
NCT00492232Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic InsomniaCOMPLETEDPHASE42007-042008-052008-03
NCT00760344Efficacy and Safety of SYR-472 in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE22007-032008-032008-03
NCT00770497Efficacy Study of Pioglitazone and Ramipril Combination Therapy in Treating Non-diabetic Hypertensive Patients.COMPLETEDPHASE22007-032008-052008-05
NCT00449813The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511)TERMINATEDPHASE42007-032008-112007-10
NCT00430625A Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) Enzyme Replacement Therapy in Gaucher DiseaseCOMPLETEDPHASE32007-02-152009-04-012009-04-01
NCT00475410Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s DiseaseCOMPLETEDPHASE32007-022009-082009-08
NCT00492011Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult VolunteersCOMPLETEDPHASE42007-022007-082007-08
NCT00430248Efficacy and Safety of Oral Febuxostat in Participants With GoutCOMPLETEDPHASE32007-022008-032008-03
NCT00399308Evaluation of Safety and Activity of Celaderm in Healing Venous Leg UlcersCOMPLETEDPHASE1, PHASE22007-01-312008-04-302008-04-30
NCT00418561Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)COMPLETEDPHASE12007-01-222008-03-272008-03-27
NCT00633139Long-term Metazym Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)COMPLETEDPHASE1, PHASE22007-01-222008-11-252008-11-25
NCT00441545Head to Head Study Against Sevelamer HydrochlorideCOMPLETEDPHASE32007-01-052008-07-312008-07-31
NCT00333515Pharmacokinetic (PK) and Safety Study of Plasma-derived Human Butyrylcholinesterase Administered IntravenouslyCOMPLETEDPHASE12007-01-012008-08-012008-04-01
NCT00432276Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32007-012009-062009-05
NCT01263470Efficacy and Safety of Alogliptin in Participants With Type 2 Diabetes in JapanCOMPLETEDPHASE22007-012007-122007-12
NCT01263483Efficacy and Safety of Alogliptin Used in Combination With α-glucosidase Inhibitor in Participants With Type 2 Diabetes in JapanCOMPLETEDPHASE2, PHASE32007-012008-042008-04
NCT00772174Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 DiabetesCOMPLETEDPHASE32007-012008-022008-02
NCT00411645Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant RecipientsCOMPLETEDPHASE32006-12-132009-05-232008-11-10
NCT00367835SPD503 (Guanfacine Hydrochloride) in ADHD Plus Oppositional SymptomsCOMPLETEDPHASE32006-12-042008-01-042008-01-04
NCT00782106Study to Determine the Dose of Recombinant Human Hyaluronidase Needed to Infuse a Full Dose of IGIV SubcutaneouslyCOMPLETEDPHASE1, PHASE22006-12-042007-11-012007-11-01
NCT00987142Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys BullosaCOMPLETEDPHASE22006-122010-052010-05
NCT00770952Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.COMPLETEDPHASE32006-122008-122008-12
NCT00413634The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET)COMPLETEDPHASE22006-11-132008-01-222008-01-22
NCT00395512Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32006-112008-022008-02
NCT00763347Efficacy and Safety Study of SYR-619 in Treating Subjects With Type 2 Diabetes MellitusTERMINATEDPHASE22006-112007-022007-02
NCT00450333Dynepo Infrequent Dosing StudyTERMINATEDPHASE32006-10-302008-07-312008-07-31
NCT00396006Efficacy and Safety Study of Augmentation Therapy With ARALAST Fraction IV-1 (Human Alpha 1 - Proteinase Inhibitor)COMPLETEDPHASE42006-10-272007-12-142007-12-14
NCT00432510Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema SubjectsCOMPLETEDPHASE12006-10-092007-02-282007-02-28
NCT00775814Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension.COMPLETEDPHASE42006-102008-092008-09
NCT00377598Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic NeuralgiaCOMPLETEDPHASE2, PHASE32006-102008-022008-02
NCT00414102Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.COMPLETEDPHASE42006-102007-092007-09
NCT00438815Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) AttacksCOMPLETEDPHASE32006-09-212009-03-312009-03-31
NCT00820885A Double-Blind Multi-Dose Tolerability and Pharmacokinetic Study of TeduglutideCOMPLETEDPHASE12006-09-062007-04-232007-04-23
NCT00760955Efficacy and Safety of TAK-583 in Subjects With Diabetic Peripheral NeuropathyCOMPLETEDPHASE22006-092008-022008-02
NCT01124656Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 DiabetesTERMINATEDPHASE32006-092007-052007-05
NCT00771004Efficacy of Pioglitazone on Myocardial Function in Patients Undergoing Coronary Stent Implantation.COMPLETEDPHASE22006-082009-022009-02
NCT00336219Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)COMPLETEDPHASE32006-082007-042006-11
NCT00365456Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM)COMPLETEDPHASE32006-072011-082011-01
NCT00755495Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic InsomniaCOMPLETEDPHASE22006-072007-032007-03
NCT00462709Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) AttacksCOMPLETEDPHASE32006-06-272009-03-312009-03-31
NCT00313144Aralast alpha1-proteinase Inhibitor Surveillance StudyTERMINATEDPHASE42006-06-092009-05-012008-12-01
NCT00568789Safety of Ramelteon in Elderly SubjectsCOMPLETEDPHASE42006-062006-092006-09
NCT00321984Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux DiseaseCOMPLETEDPHASE32006-062006-122006-12
NCT00324974The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal RefluxCOMPLETEDPHASE32006-062007-052007-05
NCT00376181Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes MellitusTERMINATEDPHASE32006-062007-052007-05
NCT00776074A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.COMPLETEDPHASE22006-062007-072007-07
NCT00325676Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342)COMPLETEDPHASE42006-06
NCT00357656Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic SurgeryCOMPLETEDPHASE42006-05-292015-12-092015-10-01
NCT00328627Efficacy and Safety of Alogliptin Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus.COMPLETEDPHASE32006-052008-032008-03
NCT00321737Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive EsophagitisCOMPLETEDPHASE32006-052007-052007-05
NCT00362115Safety and Efficacy of Azilsartan Medoxomil in Participants With Mild to Moderate HypertensionCOMPLETEDPHASE22006-052006-122006-12
NCT00312806Effect of Pantoprazole on the Symptoms of Acid Reflux Disease in Adult Patients (BY1023/M3-341)COMPLETEDPHASE32006-052007-072007-03
NCT00314795Efficacy and Safety of Peginesatide (AF37702) in the Treatment of Anemia in Participants With Chronic Kidney DiseaseCOMPLETEDPHASE22006-04-062016-10-312016-10-24
NCT00312286Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.TERMINATEDPHASE22006-042008-062008-06
NCT00117884Efficacy of 851B Gel for Treating High-Risk Cervical Human Papillomavirus Infection in Women.TERMINATEDPHASE22006-042008-062008-06
NCT00286468Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.COMPLETEDPHASE32006-042007-062007-06
NCT00316992Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary DiseaseCOMPLETEDPHASE42006-042006-112006-11
NCT00325728Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's DiseaseCOMPLETEDPHASE22006-03-212007-08-202007-08-01
NCT00306384Long-term Safety of Alogliptin in Patients With Type 2 Diabetes MellitusCOMPLETEDPHASE32006-032011-112011-11
NCT00286481Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With HypercholesterolemiaCOMPLETEDPHASE32006-032007-052007-05
NCT00286442Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes MellitusCOMPLETEDPHASE32006-032007-062007-06
NCT00289536Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia ACOMPLETEDPHASE42006-02-022007-04-012007-04-01
NCT00813527Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol LevelsCOMPLETEDPHASE22006-022007-012007-01
NCT00286455Efficacy and Safety of Alogliptin in Subjects With Type 2 DiabetesCOMPLETEDPHASE32006-022007-072007-07
NCT00286494Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32006-022007-082007-08
NCT00286429Efficacy and Safety Study of Alogliptin and Insulin in the Treatment of Type 2 Diabetes.COMPLETEDPHASE32006-022007-052007-05
NCT00202644A Study of Anagrelide and Hydroxyurea in High-Risk Essential Thrombocythemia PatientsCOMPLETEDPHASE42006-01-132015-12-152015-12-15
NCT00234702Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney DiseaseCOMPLETEDPHASE22006-01-112007-06-012007-06-01
NCT00243386Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia ACOMPLETEDPHASE42006-01-042010-06-162010-06-16
NCT00255164Efficacy and Safety of Dexlansoprazole MR on Maintaining Healing in Subjects With Healed Erosive EsophagitisCOMPLETEDPHASE32006-012006-112006-11
NCT00255151Comparison of Dexlansoprazole MR to Placebo on the Ability to Maintain Healing in Subjects With Healed Erosive EsophagitisCOMPLETEDPHASE32006-012006-112006-11
NCT00255190Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat HeartburnCOMPLETEDPHASE32006-012008-062008-06
NCT00262080Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE)COMPLETEDPHASE32005-12-312007-02-282005-12-31
NCT00242385Pharmacokinetic Study of ARALAST (Human Alpha1- PI)COMPLETEDPHASE12005-12-202006-06-052006-06-05
NCT00868127Safety of Lapaquistat Acetate in Subjects With HypercholesterolemiaCOMPLETEDPHASE32005-122007-072007-07
NCT00251719Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive EsophagitisCOMPLETEDPHASE32005-122007-012007-01
NCT00251693Efficacy and Safety of Dexlansoprazole MR and Lansoprazole on Healing of Erosive EsophagitisCOMPLETEDPHASE32005-122007-012007-01
NCT00251745Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat HeartburnCOMPLETEDPHASE32005-122006-052006-05
NCT00843154Efficacy of Candesartan on Brain Natriuretic Peptide Levels in Subjects With Chronic Heart FailureTERMINATEDPHASE32005-122008-072008-07
NCT00251758Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat HeartburnCOMPLETEDPHASE32005-122006-052006-05
NCT00249899Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With HypercholesterolemiaTERMINATEDPHASE32005-112007-032007-03
NCT00263081Efficacy of Lapaquistat Acetate Co-Administered With Current Lipid-Lowering Treatment on Blood Cholesterol Levels in Subjects With Homozygous Familial HypercholesterolemiaTERMINATEDPHASE32005-112007-032007-03
NCT00755508Efficacy and Safety of Ramelteon Combined With Gabapentin in Treating Patients With InsomniaCOMPLETEDPHASE22005-112006-092006-09
NCT00246909Determination of the Minimal Clinically Important Difference After Treatment With Pantoprazole in Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-340)COMPLETEDPHASE42005-112006-112006-11
NCT00251680Efficacy of Lapaquistat Acetate in Subjects Currently Treated With Lipid-Lowering Therapy.COMPLETEDPHASE32005-102007-052007-05
NCT00256178Efficacy of Lapaquistat Acetate and Simvastatin in Subjects With Primary Dyslipidemia.COMPLETEDPHASE32005-102007-032007-03
NCT00268697Efficacy of Lapaquistat Acetate Alone and With Ezetimibe in Subjects With Primary Dyslipidemia.COMPLETEDPHASE32005-102007-012007-01
NCT00249912Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With HypercholesterolemiaCOMPLETEDPHASE32005-102007-042007-04
NCT00202605Safety and Efficacy of SPD465 in Adults With ADHDCOMPLETEDPHASE22005-09-292006-01-062006-01-06
NCT00143663Effect of Lapaquistat Acetate on Blood Cholesterol Levels in Subjects With Elevated CholesterolCOMPLETEDPHASE32005-092006-042006-04
NCT00756041Safety Study of TAK-128 in Subjects With Diabetic Peripheral NeuropathyTERMINATEDPHASE22005-092006-092006-09
NCT00143611Efficacy & Safety of Resatorvid in Adults With Severe SepsisCOMPLETEDPHASE32005-092007-022007-02
NCT00143676Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary HypercholesterolemiaCOMPLETEDPHASE32005-082006-082006-08
NCT00261339Determination of a Questionnaire After Treatment With Pantoprazole at Full Dose and Half Dose in Adult Patients With Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/UK-506)COMPLETEDPHASE42005-08
NCT00237497Safety and Efficacy of Ramelteon in Adults With Chronic InsomniaCOMPLETEDPHASE32005-072006-102006-10
NCT00754403Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 DiabetesCOMPLETEDPHASE42005-072006-102006-10
NCT00247390Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia.COMPLETEDPHASE32005-072006-122006-12
NCT00770575Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular DiseaseCOMPLETEDPHASE22005-062006-102006-10
NCT00150592Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17COMPLETEDPHASE22005-05-122005-10-052005-10-05
NCT00174928A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux DiseaseCOMPLETEDPHASE12005-052005-082005-08
NCT00163306Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)COMPLETEDPHASE32005-05
NCT00152022Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD.COMPLETEDPHASE32005-04-252005-11-042005-11-04
NCT00151892Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative ColitisCOMPLETEDPHASE32005-04-082009-09-072009-09-07
NCT00289211C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) AttacksCOMPLETEDPHASE32005-03-142007-04-132007-04-13
NCT01005888C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) AttacksCOMPLETEDPHASE32005-03-142007-08-222007-08-22
NCT00152035Safety of SPD465 in Treating Adults With ADHD.COMPLETEDPHASE32005-03-102006-11-072006-11-07
NCT00500656Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary Angioedema (HAE)COMPLETEDPHASE32005-03-012006-07-252006-07-25
NCT00755846Safety and Efficacy Study of Alogliptin on Glycemic Control in Subjects With Type 2 Diabetes.COMPLETEDPHASE22005-032005-102005-10
NCT00229437Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral NeuropathyCOMPLETEDPHASE22005-032006-052006-05
NCT00671190Safety and Efficacy of Ramelteon in Healthy SubjectsCOMPLETEDPHASE22005-032005-052005-05
NCT00672724Efficacy of Ramelteon in Adults With Chronic InsomniaTERMINATEDPHASE32005-022005-082005-08
NCT00150579Efficacy and Safety of SPD465 in Adults With ADHDCOMPLETEDPHASE32005-01-272005-06-142005-06-14
NCT00160121Efficacy and Safety of Fosrenol in Treating Elevated Serum Phosphate Levels in Adults With End Stage Renal DiseaseCOMPLETEDPHASE42005-01-102005-12-132005-12-13
NCT00172185Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome Who Completed Protocol CL0600-004 (NCT00081458)COMPLETEDPHASE32005-01-102008-01-242008-01-24
NCT00172120Open Label ExtensionCOMPLETEDPHASE32005-01-102006-10-272006-10-27
NCT00151918Efficacy and Safety of Lanthanum Carbonate and Sevelamer Hydrochloride in Patients Receiving Haemodialysis for End Stage Renal DiseaseCOMPLETEDPHASE32005-01-072005-08-222005-08-22
NCT00220818A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.COMPLETEDPHASE12005-012005-072005-07
NCT00097695Subcutaneous Treatment With Icatibant for Acute Attacks of Hereditary AngioedemaCOMPLETEDPHASE32004-12-282006-07-172006-07-17
NCT00189982Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101COMPLETEDPHASE2, PHASE32004-12-172006-11-102006-11-10
NCT00762684Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusTERMINATEDPHASE32004-112004-122004-12
NCT00487994Safety and Efficacy of Lapaquistat Acetate Taken Alone and With Atorvastatin in Subjects With Primary DyslipidemiaCOMPLETEDPHASE32004-112007-052007-05
NCT00762957Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.TERMINATEDPHASE32004-112004-122004-12
NCT00223925Maribavir for Prevention of CMV After Stem Cell TransplantsCOMPLETEDPHASE22004-10-282006-04-052006-04-05
NCT00630747Extension of Study TKT024 Evaluating Long-Term Safety and Clinical Outcomes in MPS II Patients Receiving IdursulfaseCOMPLETEDPHASE2, PHASE32004-09-132008-01-312008-01-31
NCT00391625Open-Label Extension Study Evaluating Long Term Safety in Patients With Type 1 Gaucher Disease Receiving DRX008A (ERT)COMPLETEDPHASE1, PHASE22004-09-132008-01-312008-01-31
NCT00555880Study to Assess the Benefit of Midodrine in the Treatment of Patients With Neurogenic Orthostatic HypotensionCOMPLETEDPHASE42004-09-082005-03-212005-03-21
NCT00864643Efficacy and Safety of Lapaquistat Acetate Coadministered With Atorvastatin in Subjects With HypercholesterolemiaCOMPLETEDPHASE22004-092005-022005-02
NCT00151996Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)COMPLETEDPHASE22004-08-162004-12-272004-12-27
NCT00759551Efficacy and Safety of Azilsartan in Subjects With Essential HypertensionCOMPLETEDPHASE22004-082005-062005-06
NCT00760864Safety and Efficacy of TAK-715 in Subjects With Rheumatoid ArthritisCOMPLETEDPHASE22004-082005-092005-09
NCT00762736Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE22004-072005-102005-10
NCT00928148The Safety and Efficacy of SPD465 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)COMPLETEDPHASE22004-06-142004-11-202004-11-20
NCT00084084Replagal Enzyme Replacement Therapy for Children With Fabry DiseaseCOMPLETEDPHASE22004-06-102011-06-152011-06-15
NCT00081458Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel SyndromeCOMPLETEDPHASE32004-05-252007-07-062007-07-06
NCT00151931Efficacy and Tolerability of Treatment With Lanthanum Carbonate in Patients With End Stage Renal Disease Receiving DialysisCOMPLETEDPHASE32004-05-112006-01-122006-01-12
NCT00157157Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A PatientsCOMPLETEDPHASE32004-04-012009-09-112009-09-11
NCT01011751Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate AdenocarcinomaCOMPLETEDPHASE32004-042007-122007-12
NCT00150618Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17COMPLETEDPHASE32004-03-302004-10-072004-10-07
NCT00308438Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008COMPLETEDPHASE22004-03-012006-06-012005-11-01
NCT00157092Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin DeficiencyCOMPLETEDPHASE1, PHASE22004-03-012004-10-142004-10-14
NCT00557960ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHDCOMPLETEDPHASE32004-02-252004-10-252004-10-25
NCT00150566Efficacy and Safety of Lanthanum in Controlling Serum Phosphate Levels in Subjects With End Stage Renal Disease Who Require Treatment for High Levels of Phosphate in Their BloodCOMPLETEDPHASE32004-02-092005-10-082005-10-08
NCT00172172Calcium Supplementation in Postmenopausal WomenCOMPLETEDPHASE32004-01-102005-03-112005-03-11
NCT00172094Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine HeadachesCOMPLETEDPHASE22003-12-312004-07-312004-06-30
NCT00548574Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative ColitisCOMPLETEDPHASE32003-12-042004-10-202004-10-20
NCT00151944Safety and Tolerability of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis.COMPLETEDPHASE32003-11-262006-03-132006-03-13
NCT00072839Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's DiseaseCOMPLETEDPHASE22003-11-122005-07-282005-07-28
NCT01826916EDEMA2: Evaluation of DX-88's Effect in Mitigating AngioedemaCOMPLETEDPHASE22003-11-012006-01-012005-12-01
NCT00762190Study of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusTERMINATEDPHASE32003-112004-122004-12
NCT00762112Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusTERMINATEDPHASE32003-112004-122004-12
NCT00763022Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32003-112004-122004-12
NCT00759720Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.TERMINATEDPHASE32003-112004-122004-12
NCT00672919Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.COMPLETEDPHASE42003-112004-082004-08
NCT00074906Venticute in Patients With Pneumonia or Aspiration of Gastric Contents and Intubation/Ventilation/Oxygenation Impairment (BY2001/M1-007)COMPLETEDPHASE32003-112008-062008-03
NCT00225264Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.COMPLETEDPHASE32003-102006-052006-05
NCT00503243Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative ColitisCOMPLETEDPHASE32003-09-302005-01-172005-01-17
NCT00069641Iduronate-2-sulfatase Enzyme Replacement Therapy in Mucopolysaccharidosis II (MPS II)COMPLETEDPHASE2, PHASE32003-09-182005-03-162005-03-16
NCT00157118Efficacy and Safety Study of Protein C Concentrate in Subjects With Severe Congenital Protein C DeficiencyCOMPLETEDPHASE2, PHASE32003-08-222005-03-172005-03-17
NCT00506727Analog Classroom Study Comparison of ADDERALL XR With STRATTERA in Children Aged 6-12 With ADHDCOMPLETEDPHASE42003-08-052004-07-022004-07-02
NCT00672802Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary DiseaseCOMPLETEDPHASE22003-082004-032004-03
NCT00225277Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes MellitusCOMPLETEDPHASE32003-072007-102007-10
NCT00672061Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep ApneaCOMPLETEDPHASE22003-072003-122003-12
NCT00175032A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose AspirinCOMPLETEDPHASE32003-072004-072004-07
NCT00175019Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010COMPLETEDPHASE32003-072007-022007-02
NCT00671632Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug AbuseCOMPLETEDPHASE22003-062003-122003-12
NCT00175045Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive EsophagitisCOMPLETEDPHASE22003-062003-102003-10
NCT00507065Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)COMPLETEDPHASE32003-05-282004-03-242004-03-24
NCT00162019Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A PatientsCOMPLETEDPHASE32003-03-312004-08-242004-08-24
NCT00545389Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476COMPLETEDPHASE22003-02-102004-10-202004-10-20
NCT00671086Efficacy of Ramelteon in Subjects With Chronic InsomniaCOMPLETEDPHASE32003-022004-092004-09
NCT00174915Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.COMPLETEDPHASE32003-022004-042004-04
NCT00152009Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17COMPLETEDPHASE32003-01-292003-08-232003-08-23
NCT00162006Efficacy and Safety Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Adult Subjects With Chronic Idiopathic Thrombocytopenic PurpuraCOMPLETEDPHASE22003-01-132003-12-032003-12-03
NCT00161707Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin DeficiencyCOMPLETEDPHASE1, PHASE22003-01-072003-10-012003-10-01
NCT00671125Study of Efficacy of Ramelteon in Adults With Chronic InsomniaCOMPLETEDPHASE32003-012003-092003-09
NCT00656994Long-Term Efficacy of Ramelteon on Endocrine Function in Adult Subjects With Chronic InsomniaCOMPLETEDPHASE32003-012004-072004-07
NCT00671567Ramelteon in Adults With Chronic InsomniaCOMPLETEDPHASE32002-122003-092003-09
NCT00676260Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With InsulinCOMPLETEDPHASE22002-122004-082004-08
NCT00671255Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic InsomniaCOMPLETEDPHASE32002-122004-012004-01
NCT00671398Efficacy of Ramelteon on Transient Insomnia in Healthy AdultsCOMPLETEDPHASE32002-122003-052003-05
NCT00150540A Long Term Study of Lanthanum Carbonate in Patients Requiring Dialysis Who Have Ived Lanthanum Carbonate in Previous Studies Defined by the Protocol.COMPLETEDPHASE32002-10-142005-06-292005-06-29
NCT00671294Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia.COMPLETEDPHASE32002-102003-072003-07
NCT00046163A Phase IV Study in Subjects With Neurogenic Orthostatic HypotensionTERMINATEDPHASE42002-09-052003-08-062003-08-06
NCT00050076Safety and Efficacy Study of Once and Twice Daily Doses of MCC-135 in Subjects With Congestive Heart Failure.COMPLETEDPHASE22002-082003-082003-08
NCT00102440Febuxostat Versus Allopurinol Control Trial in Subjects With GoutCOMPLETEDPHASE32002-072004-022004-02
NCT00157079Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency DisordersCOMPLETEDPHASE32002-06-252003-12-162003-12-16
NCT00161993Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)COMPLETEDPHASE22002-06-132003-09-242003-09-24
NCT00157040Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia ACOMPLETEDPHASE2, PHASE32002-06-072005-01-042005-01-04
NCT01135368Safety and Efficacy of Lansoprazole in Patients With Reflux DiseaseCOMPLETEDPHASE42002-062008-092008-09
NCT00034281Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2COMPLETEDPHASE12002-062003-092003-09
NCT00915135Efficacy and Safety of Ramelteon on Chronic InsomniaCOMPLETEDPHASE22002-052003-122003-12
NCT00157053Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients - A Continuation of Clinical Study 069901COMPLETEDPHASE2, PHASE32001-11-222004-08-032004-08-03
NCT00172133Open Label Extension Study of PREOSCOMPLETEDPHASE32001-10-162005-04-132005-04-13
NCT00174993Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 DiabetesCOMPLETEDPHASE32001-052005-012005-01
NCT00521742Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac DiseaseCOMPLETEDPHASE32001-032003-012003-01
NCT00174941Long-Term Safety of Febuxostat in Subjects With Gout.COMPLETEDPHASE22001-032006-122006-12
NCT00157105Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing SurgeryCOMPLETEDPHASE2, PHASE32001-02-122004-08-032004-08-03
NCT00174967Dose-Response, Safety and Efficacy of Febuxostat in Subjects With GoutCOMPLETEDPHASE22001-012001-072001-07
NCT00012259Troxacitabine in Treating Patients With Chronic Myelogenous LeukemiaCOMPLETEDPHASE22000-12-112002-03-272002-03-27
NCT00494312Safety Study of Pioglitazone Compared To Glyburide on Liver FunctionCOMPLETEDPHASE42000-102005-062005-06
NCT00261300Long-term Pantoprazole Trial in Patients With Symptoms of Chronic Acid Peptic Complaints (BY1023/VMG-708)COMPLETEDPHASE32000-102008-072007-09
NCT00331487Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and DyslipidemiaCOMPLETEDPHASE32000-092004-032004-03
NCT00521820Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart FailureTERMINATEDPHASE32000-062003-102003-10
NCT00172081TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal OsteoporosisCOMPLETEDPHASE32000-04-272003-11-072003-11-07
NCT01122121Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate CancerCOMPLETEDPHASE32000-032009-062008-12
NCT00046475A Study for Patients With Neurogenic Orthostatic HypotensionCOMPLETEDPHASE41997-12-011999-11-241999-11-24
NCT00003056Prevention of Graft-Versus-Host Disease in Patients With Advanced Leukemia or Lymphoma Who Are Eligible for Peripheral Stem Cell TransplantationTERMINATEDPHASE31997-04-012003-06-012003-06-01
NCT00817739Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,cCOMPLETEDPHASE21996-122008-122005-09
NCT00172107A Study to Assess the Safety and Efficacy of 3 Doses of ALX1-11 (50, 75, and 100µg) in the Treatment of Postmenopausal OsteoporosisCOMPLETEDPHASE21995-05-181997-03-241997-03-24
NCT01433393Double-blind Comparative Study of TAK-875COMPLETEDPHASE32012-092012-09
NCT01452698Efficacy of TAK-438 Compared to AG-1749 (Lansoprazole) in the Treatment of Erosive EsophagitisCOMPLETEDPHASE32012-082012-08
NCT01499693Magnesium Pantoprazole 20mg b.i.d. vs Magnesium Pantoprazole 40mg q.d. on Intragastric Acid InhibitionWITHDRAWNPHASE3
NCT00241163TachoComb S Versus Standard Surgical Treatment in Surgical Resection of Renal Tumour (TC-015-IN)COMPLETEDPHASE3